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ABSTRACT 
In Chapter 1 a review of the literature concerning aspects of 
erythrocyte membrane transport and metabolism, and purine and 
pyrimidine metabolism is presented. 
The effects of pH, p0 2 and inorganic phosphate (Pi) on the 
uptake and metabolism of hypoxanthine by erythrocytes has 
been studied in Chapter 2. Uptake of hypoxanthine and 
accumulation of inosine 5'-monophosphate (IMP) were markedly 
increased at acid pH, high external phosphate concentrations, 
and low p0 2 • Release of accumulated IMP as hypoxanthine 
occurred at alkaline pH values and low external phosphate 
concentrations. Conditions favouring IMP accumulation gave 
rise, in the absence of hypoxanthine, to a corresponding 
increase in 5'-phosphoribosyl-1-pyrophosphate (PRPP). 
Intracellular phosphate concentrations were markedly pH 
dependent and a model is presented whereby hypoxanthine 
uptake and release are controlled by intracellular 
concentrations of inorganic phosphate and 2,3-
bisphosphoglycerate (2,3-DPG). These allosteric effectors 
influence, in opposing ways, two enzymes governing IMP 
accumulation, namely PRPP synthetase and 5'-nucleotidase. 
These metabolic properties suggest that the erythrocyte could 
play a role in the removal of hypoxanthine from anoxic 
tissue. 
1V 
In Chapter 3 the kinetics and mechanism of transport of 
orotate across the human erythrocyte membrane and the effect 
of pH and inorganic phosphate on its metabolism (in the 
erythrocyte) have been studied. It has been shown that 
orotate enters erythrocytes with non-saturable kinetics and 
with a capacity of 190 ~moles/1 packed cells/min at a 
concentration of 4-6 mmolar. The presence of competition 
for transport by a number of anions and the lack of 
competition by uridine is indicative of transport by a 
general anion transporter, with the ability for concentrative 
uptake in the absence of other external anions being 
compatible with transport via a ping-pong mechanism. 
Inhibition of transport by the specific band 3 inhibitors 
DIDS and CHCA confirm that transport is via the band 3 anion 
transporter. This explains the lack of significant uptake 
of orotate by most differentiated tissues which lack the 
intact band 3 protein. 'However, the demonstration of band 3 
in rat .hepatocytes (Cheng and Levy, 1980) provides a 
mechanism for the orotate transport·which has been opserved 
in liver (Handschumacher and Coleridge, 1979). 
Changes in pH and inorganic phosphate (Pi) concentrations 
have been shown to have marked effects on the relative 
quantities of metabolic products produced by the erythrocyte 
from orotate. There was an increase in orotate metabolised 
with increasing Pi, an effect augmented by lowering the pH, 
and most easily explained by the allosteric activation of 
PRPP synthetase by Pi. The increase in UTP levels with 
v 
decreasing pH may be the consequence of both increased PRPP 
availability for the formation of uridine nucleotide from 
orotate, and decreased conversion of UMP to uridine by 
pyrimidine S'-nucleotidase, which is known to be inhibited by 
phosphate. The accumulation of UDP sugars is optimal at a 
phosphate concentration of 10 mmolar, which is unexplained 
but would be compatible with an inhibitory effect of Pi on 
CTP synthetase. 
A PRPP wasting cycle at alkaline pH values is proposed to 
explain the apparent paradox where no PRPP was observed to 
accumulate in erythrocytes (Chapter 2) at pH values of 7.6 
and above in the presen6e of 10 mmolar phosphate a~d no ad~ed 
hypoxanthine, yet the metabolism of orotate, which is a PRPP 
utilising reaction, at alkaline pH values was readily 
demonstrable here. This (apparent paradox) can be resolved 
if one assumes that even in the absence of added hypoxanthine 
and demonstrable intracellular IMP there are sufficient 
quantities of hypoxanthine and/or IMP to maintain a PRPP 
wasting cycle at alkaline pH values. The cycle is 
interrupted at acidic pH values as phosphate levels rise and 
inhibit S'-nucleotidase, an effect augmented by the 
decreasing levels of 2,3-DPG which accompany decreasing pH. 
This wasting cycle has recently been confirmed by P. Berman 
(unpublished). 
The kinetics of orotate uptake by erythrocytes. and its 
eventual release as uridine provides a role for the 
vi 
erythrocyte in the transport and distribution of pyrimidines 
to peripheral tissues. A model is proposed and involves the 
de novo production of orotate in the liver. In the next 
step erythrocytes take up the orotate secreted by the liver 
into the circulation, convert it into an intermediate buffer 
store of uridine nucleotides, whose distribution is a 
function of pH and phosphate concentration, and eventually 
release it as uridine, which is a readily available form of 
pyrimidine for utilisation by peripheral nucleated cells. 
The enhancement of uptake of labelled orotate into nucleic 
acids of cultured cells is demonstrated here. The 
degradative half of the cycle proposes th~l uracil and p-
alanine are the predominant degradative forms of pyrimidines 
produced by peripheral cells, and their ultimate metabolic 
fate is complete catabolism in the liver to co 2 and water. 
\In the final chapter the possible role of the human 
erythrocyte in the prevention of reperfusion injury has been 
investigated. The development of a model of renal ischaemia 
in the rat is described. The ability of human erythrocytes, 
"primed" by preincubating in acid medium of high Pi 
concentration and low p0 2 , to take up hypoxanthine in a 
concentrative manner when perfused through ischaemic rat 
kidney is demonstrated. Attempts to demonstrate improved 
survival and renal function in rats with "primed" human 
erythrocytes 
unsuccessful. 
prior to reperfusion were, however, 
vii 
It is further demonstrated that "unprimed" human 
erythrocytes, resident in ischaemic rat kidney for 3 hours, 
take up hypoxanthine and convert it to IMP. 
that erythrocytes could play a physiological 
prevention of reperfusion injury. 
This suggests 
role in the 
I wish to thank: 
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ABBREVIATIONS 
ADA adenosine deaminase 
ADP adenosine 6'-diphosphate 
Ald fructoaldolase 
AMP adenosine 6'-monophosphate 
APRT adenosine phosphoribosyl transferase 
ATP : adenosine 6'-triphosphate 
CHCA alpha-cyano-4-hydroxycinnamate 
Ci Curie (2.2 x 1012 dpm) 
cpm counts per minute 
DHAP dihydroxyacetone phosphate 
DIDS 4,4-diisothiocyanostilbene-2,2'-disulfonate 
DHEH Dulbeccos minimal essential medium 
DNA deoxyribonucleic acid 
1,3-DPG 1,3-bisphosphoglycerate 
2,3-DPG 1 2,3-bisphosphoglycerate 
DPGH bisphosphoglycerate mutase 
DPGP 2,3-bisphosphoglycerate phosphatase 
dpm 
E-4-P 
EHP 
En 
FAD 
FCS 
FOP 
P-1,6-P 
F~6-P 
: disintegrations per minute 
erythrose-4-phosphate 
Embden-Heyerhof pathway 
enolase 
flavine adenine dinucleotide (oxidised) 
foetal calf serum 
fructose-1,6-bisphosphatase 
fructose-1,6-bisphosphate 
fructose-6-phosphate 
g acceleration due to gravity 
GOP guanosine 6'-diphosphate 
G-1,6-DP: glucose-1,6-bisphosphate 
G-1-P glucose-1-phosphate 
G-6-P 
GA-3-P 
GAPD 
glucose-6-phosphate 
glyceraldehyde-3-phosphate 
glyceraldehyde-3-phosphate dehydrogenase 
GalK galactokinase 
Gal-1-P galactose-1-phosphate 
Gal-l-PUT: galactose-1-phosphate uridyl transferase 
GSH : glutathione (reduced) 
GSSH 
GTP 
h 
Hb 
HEPES 
HGPRT 
HK 
HPLC 
HPRT 
Hx 
IDP 
IMP 
In 
ITP 
kDa 
Ki 
Km 
L 
LDH 
LE 
mg 
min 
Jnl 
mmolar 
mM 
NAD 
NADH 
NADP 
NADPH 
xiii 
glutathione (oxidised) 
: guanosine 5'-triphosphate 
hour 
haemoglobin 
4-(2-hydroxymethyl)-1-piperazineethanesulfonic 
acid 
hypoxanthine-guanine phosphoribosyl transferase 
hexokinase 
high pressure liquid chromatography 
: hypoxanthine-guanine phosphoribosyltransferase 
hypoxanthine 
inosine 5'-diphosphate 
inosine 5'-monophosphate 
inosine 
inosine 5'-triphosphate 
kilodalton 
inhibition constant 
Michaelis constant 
litre 
lactate dehydrogenase 
Long Evans 
micro 
milligram 
minute 
millilitre 
millimolar 
millimolar 
nicotinamide adenine dinucleotide (oxidised) 
nicotinamide adenine dinucleotide (reduced) 
nicotinamide adenine dinucleotide phosphate 
(oxidised) 
nicotinamide adenine dinucleotide phosphate 
(reduced) 
NAP-taurine: N-(4-azido-2-nitrophenyl)-2-aminoethyl-
5'NT 
-0 • 2 
OA 
OH· 
sulfonate 
purine 5'-nucleotidase 
superoxide 
orotate 
hydroxyl radical 
OHP 
PCA 
PEP 
PFK 
2-PG 
3-PG 
6-PG 
PGA 
PGI 
PGK 
6-PGL 
PGH 
6-PGH 
6-PGnD 
Pi 
PK 
PNP 
PRPP 
RBC 
RNA 
R-5-P 
Ru-5-P 
SDS 
SOD 
S-7-P 
TOP 
TK 
TPI 
UDP 
UDPG 
UDPGal 
UDPGE 
UHP 
UTP 
XD 
xo 
X-P 
X-5-P 
x~v 
: orotate 5'-monophosphate 
perchloric acid 
phosphoenol pyruvate 
phosphofructokinase 
2-phosphoglycerate 
3-phosphoglycerate 
6-phosphogluconate 
phosphoglycerate 
phosphohexose isomerase 
phosphoglycerate kinase 
6-phosphogluconolactone 
phosphoglycerate mutase (phosphoglucomutase) 
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6-phosphogluconate dehydrogenase 
inorganic phosphate 
pyruvate kinase (purine kinase in Fig. 1.3) 
purine nucleoside phosphorylase 
5'-phosphoribosyl a-1-pyrophosphate 
erythrocyte 
ribonucleic acid 
ribose-5-phosphate 
ribulose-5-phosphate 
sodium dodecyl sulphate 
superoxide dismutase 
sedoheptalose-7-phosphate 
deoxythymidine 5'-diphosphate 
transketolase 
triosephosphate isomerase 
uridine 5'-diphosphate 
uridine 5'-diphosphate glucose 
s uridine 5'-diphosphate galactose 
uridine 5'-diphosphate glucose epimerase 
uridine 5'-monophosphate 
uridine 5'-triphosphate 
xanthine dehydrogenase 
xanthine oxidase 
phosphorylated glycolytic intermediates 
xylulose-5-phosphate 
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·1.1 INTRODUCTION 
CHAPTER 1 
GENERAL INTRODUCTION 
This thesis is to a large extent concerned with studies using 
the human erythrocyte. It would seem, therefore, that the 
brief review of general erythrocyte metabolism which follows 
is appropriate. Furthermore, more detailed accounts of 
specific areas dealt with in this thesis are given. These 
include the subjects of anion transport; purine transport and 
metabolism, and the physiology of 2,3-bisphosphoglycerate 
(2,3-DPG). 
1.2 ERYTHROCYTE MATURATION 
The human erythFocyte as ordinarily released into the 
circulation has lost its nucleus and associated DNA, and is 
therefore not capable of RNA synthesis. The residual 
messenger RNA and associated ribosomes, after loss of the 
nucleus, persist briefly (2 or 3 days) during which stage the 
cell is called a reticulocyte and is capable of some protein 
synthesis. It also briefly retains some mitochondria during 
this period. For the remainder of its life span of some 120 
days the cell is incapable of protein synthesis, and must 
function with the proteins it has previously synthesised. 
Reticulocytes, unlike mature erythrocytes, are also able to 
synthesize lipids, haem and purines, and have an active 
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tricarboxylic acid (TCA) cycle and oxidative phosphorylation 
system. 
After the reticulocyte stage, the cell loses its oxidative 
phosphorylation system. Oxygen consumption and carbon 
dioxide production by the mature red cell are much reduced 
and occur only through the pentose phosphate shunt pathway. 
Only remnants of the TCA cycle remain in the form of certain 
enzymes, and the cycle is inoperable as a system. The 
mature erythrocyte has lost most or all of its capabilities 
for lipid synthesis as well. The mature cell is also 
incapable of de novo purine sythesis. Purine metabolism 
will be considered in greater detail in Section 1.8. 
1.3 GLYCOLYSIS IN THE ERYTHROCYTE 
Glycolysis in the mature erythrocyte, unlike all other cells 
in the body, is anaerobic, irrespective of whether oxygen is 
present or not (Surgenor, 1975). The glycolytic pathway, 
which is also called the Embden-Meyerhof pathway (EMP), and 
the connected pentose shunt pathway, 
critically 
are shown in Fig. 
important to 
1.1. 
Glucose metabolism is 
erythrocyte, first to 
functions, and second, 
provide the energy for 
to modulate haemoglobin 
the 
various 
function. 
Murphy (1960) has studied the proportion of substrate which 
flows through the pentose shunt under laboratory conditions 
designed to simulate in vivo conditions as closely as 
possible, and concludes that 10% normally goes through the 
pentose shunt, the other 90% passing down the EMP. The 
/ 
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Figure 1.1. The major pathways of carbohydrate metabolism in 
mature mammalian erythrocytes (Brewer, G.J., 1974). 
~ 
The pentose shunt is enclosed in the dotted box. 
represent enzymatic steps. 
The arrows 
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proportion of carbohydrate substrate passing through the 
pentose shunt can increase dramatically as a result of 
different kinds of stimuli, the 10% figure representing, 
then, a form of basal traffic. The known general functions 
of the pentose shunt in the erythrocyte are reduction of 
nicotinamide adenine dinucleotide phosphate (NADP) and hence 
indirectly glutathione (GSSG), and the generation of s·~ 
' 
phosphoribosyl alpha-1-pyrophosphate (PRPP). 
1.4 THE PENTOSE PHOSPHATE SHUNT AND PRPP PRODUCTION 
The major features of the pentose shunt are shown in Fig. 1.2 
(Eaton and Brewer, 1974). Production of PRPP is a function 
of·the pentose shunt in the mature erythrocyte. It may be 
used by this cell for the synthesis of adenine nucleotides. 
Herschko et al. (1969) have demonstrated that the synthesis 
of PRPP by phosphoribosyl pyrophosphate synthetase (PRPP 
synthetase) is controlled by a balance between naturally 
present inhibitors and activators. These authors reported 
that inorganic phosphate (Pi) was an effective activator of 
PRPP synthesis and that ADP, GOP and 2,3-DPG were potent 
inhibitors. 2he activity of PRPP Bynthetase within the 
whole cell, then, will be determined by the nett effect of 
these activating and inhibiting compounds. 
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Figure 1.2. The pentose shunt (Eaton and Brewer, 1974). 
Reactions are drawn unidirectionally although many are 
reversible. Circled numbers refer to the following enzymes: 
(1) glucose-6-phosphate dehydrogenase; (2) 6-phosphoglucono-
lactonase; (3) 6-phosphogluconate dehydrogenase; ( 4 ) 
ribose-5-phosphate isomerase; ( 5 ) xylulose-5-phosphate 
epimerase; (6) transketolase; (7) transaldolase; ( 8 ) 
, 
transketolase; (9) glutathione reductase; (10) 5-
phosphoribosyl-1-pyrophosphate synthetase. Abbreviations 
\ 
(see Fig. 1.1 for abbreviations not appearing here): E-4-P, 
erythrose-4-phosphate; 
phosphoglucono~actone; 
6-PG, 6 phosphogluconate; 6-PGL, 6-
PRPP, 
, 
5-phosphoribosyl-1-pyro-
phosphate; R-5-P, ribose-5-phosphate; Ru-5-P, ribulose-5-
phosphate; S-7-P, sedoheptulose-7-phosphate; X-5-P, 
xylulose-5-phosphate. 
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1.5 PHOSPHORIBOSYLPYROPHOSPHATE CPRPP> SYNTHETASE AND 
PHOSPHORIBOSYLPYROPHOSPHATE 
PRPP synthetase from all sources has an absolute requirement 
for Pi for its activity (Wong and Hurray, 1969). The 
apparent Km (or Ka) of Ehrlich ascites cell enzyme for Pi is 
3.3 mH (Roth et ~., 1974a,b). Removal of Pi leads to 
immediate and complete loss of enzyme activity (Fox and 
Kelley, 1971a and b). In Sperling's view, the rate of PRPP 
synthesis in liver is largely regulated by Pi (Sperling, 
1977). The enzyme also requires magnesium or manganese. 
With purified human PRPP synthetase the Km value for ribose-
5-phosphate (R-5-P) is 3.3 x 10-5 H, and for magnesium ATP is 
1.4 x 10-5 H (Fox and Kelley, 1972). 
The smallest native form of PRPP synthetase from human 
erythrocytes has a molecular weight of 60,000 and consists of 
two subunits of equal molecular weight (Fox and Kelley, 
1971a). In the presence of saturating concentrations of ATP 
and magnesium chloride, the enzyme associates into two heavy 
forms with molecular weights of about 720,000 and 1.2 
million. Ribose-5-phosphate does not alter the aggregation 
state of the enzyme. The associated enzyme appears to be 
the active form. In addition to the heterogeneity of 
molecular size, human PRPP synthetase exhibits striking 
electrophoretic heterogeneity. Electrophoretic variants of 
the erythrocyte enzyme were found in 2.5 percent of 200 
subjects. In addition, human organs obtained at autopsy 
disclosed a unique electrophoretic mobility for nearly each 
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in human cells (Fox and Kelley, 1971b). However, the Ki of 
the enzyme for 2,3-DPG is approximately equal (5.3 mH) to its 
concentration in erythrocytes. Therefore, 2,3-DPG may 
participate in the control of PRPP synthesis. 
A large number of nucleotides, including AMP, ADP, GOP, GTP, 
lOP, ITP, TOP, NAD, NADPH and FAD inhibit PRPP synthetase by 
a third mechanism which is non-competitive with respect to 
both magnesium-ATP and R-5-P (Fox and Kelley, 1972; and 
.Green and Hartin, 1973). In general terms the di- and 
triphosphate derivatives are more potent inhibitors than the 
monophosphates. This group of inhibitors has a low affinity 
for the enzyme, presumably binds at a single site, and 
regulates by a mechanism called "heterogeneous metabolic pool 
inhibition". This term means that the degree of inhibition 
depends on total nucleotide concentration and is largely 
independent of specific nucleotide composition. Atkinson 
(1968) postulates that the activity of a biosynthetic 
reaction is controlled by the "energy charge" of the cell 
(Atkinson, 1968), as well as by feedback· inhibition: 
"Energy charge": = ATP + ~ADP 
ATP + ADP + AMP 
This concept predicts that the synthesis of PRPP will be 
inhibited by nucleoside diphosphates and monophosphates, 
irrespective of specific feedback effects. 
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Steady state levels of PRPP will be determined by the balance 
achieved between rates of production and of utilization. 
Data on intracellular concentrations of PRPP are fragmentary. 
Values in normal human erythrocytes range from 2 to 7 
micromolar (Green and Seegmiller, 1969; Fox et Al•r 1970, 
and Van Maris et al., 1980). 
Methylene blue (reduced) will raise the intracellular 
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concentration of PRPP in human fibroblasts in tissue culture, 
and in human erythrocytes in vitro (Wyngaarden and Kelley, 
1983), presumably by accelerating the regeneration of NADP in 
the oxidative pathway of glucose metabolism and thereby 
stimulating the rate of production of R-5-P. In addition, 
ethanol has been shown to raise PRPP concentrations in 
isolated mouse hepatic cells (Nishida e~ al., 1979). 
PRPP concentration values are elevated in cells with 
deficient hypoxanthine-guanine phosphoribosyltransferase 
(HPRT) activity (Rosenbloom et Al•r 1968). HPRT-deficient 
fibroblasts show accelerated rates of purine biosynthesis. 
Intracellular PRPP concentrations may be reduced by 
stimulating PRPP consumption with allopurinol, orotic acid, 
adenine or 2,6-diaminopurine (Wyngaarden and Kelley, 1983). 
Such measures reduce the rate of purine biosynthesis de ~~ 
except in HPRT-deficient cells which have a surfeit of PRPP. 
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1.6.1 Membrane transport of anions in erythrocytes: the 
band 3 protein 
Anion transport across the eryth~ocyte membrane is not 
energy-dependent and is facilitated by 
3 
a major 
because 
integral 
of its membrane protein known as band 
electrophoretic properties 
(Fairbanks et ~., 1971). 
in SDS polyacrylamide gel 
The structural and kinetic 
properties of this general anion transporter have been 
extensively investigated (Cabantchik and Rothstein, 1974; 
Jenkins and Tanner, 1975; Ho and Guidotti, 1975; Steck et 
al., 1976; Markowitz and Marchesi, 1981; and Macara and 
Cantley, 1981) and few topics have been so thoroughly 
recent years as anion exchange in human reviewed in 
erythrocytes 
Brahm, 1986; 
(see for example, Rothstein et al., 1981; 
Knauf, 1979; Passow, 1986). Some evidence 
that the band 3 protein is the anion carrier is provided by 
the fact that erythrocyte membranes depleted of most proteins 
except band 3, retain anion transport and the transport in 
these membranes has the same properties as that present in 
intact erythrocytes (Ross and McConell, 1977). Furthermore, 
band 3 has been incorporated into phospholipid vesicles that 
were then able to transport anions (Ross and McConnell, 
1977). 
Rapid transport of anions is a specialized function of the 
erythrocyte membrane that enables these cells to play an 
important role 
of band 3, the 
in blood carbon dioxide transport. Instead 
name capnophorin was proposed by Wieth and 
(\ 
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Bjerrum (1983) to characterise the physiological function of 
the transport system: "Kapnos is the Greek word for smoke. 
Carbon dioxide is the fume of oxidative metabolism, and 
hypercapnia is the well-known pathophysiological consequence 
of impaired co 2 elimination from the organism". co 2 formed 
in the tissues rapidly diffuses into erythrocytes where it is 
converted to H+ and Hco 3 - by carbonic anhydrase. The 
protons are buffered by haemoglobin, and the band 3 protein 
in the erythrocyte membrane mediates the (non-energy 
dependent) exchange of cellular 
(Hamburger, 1891). This removes the product of the carbonic 
anhydrase reaction and permits co 2 to be stored in the form 
of plasma-bicarbonate, thus greatly increasing the C0 2 -
carrying capacity of the blood (Wieth et ~., 1982), and 
explaining the relatively high Cl- concentration of 50 mH 
found in erythrocytes (Caraway, 1962). 
For this process to be physiologically significant, the 
exchange must take place within the time of passage of an 
erythrocyte through a pulmonary capillary, which varies from 
0.7 seconds at rest to 0.3 seconds during exercise (Wieth, 
1979; Wieth et al., 1982). Chloride and bicarbonate self-
exchange is very fast with half-times of about 40 to 50 
milliseconds at 37°C (Tosteson, 1959; Brahm, 1977), more 
than a million times faster than the corresponding rates of 
cation exchange (Wieth, 1972). Even so, the rate of 
exchange with physiological gradients of Cl- and HCo3 - is, 
nevertheless, only barely sufficient to permit anion 
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equilibration under conditions of exercise, and the anion 
exchange actually becomes rate-limiting for co2 transport 
under exercise (Wieth et al., 1982). Perhaps it is because 
of the need to maximise the transport .rate that the 
erythrocyte contains such a large amount of band 3 protein: 
there are estimated to be 800 000 to 1 200 000 molecules of 
the band 3 protein per cell (Knauf, 1979), and it is the most 
abundant protein of the erythrocyte membrane, constituting 
some 25 to 30 per cent of the total membrane protein. 
The low permeability to cations and a specialised system for 
rapid exchange of anions (Wieth, 1972; George Fortes, 1977) 
in conjunction with an active cation pump system, provides a 
means of regulating cell volume at low energy cost (Tosteson, 
1964). 
On SDS polyacrylamide gel electrophoretograms the 95 kDa band 
3 protein extends over a broad molecular weight range of at 
least 10 kDa. This diffuse appearance of the band 
disappears 
(Mueller et 
1984), in 
after suitable treatment 
~-, 1979; Fukuda et ~., 
agreement with the suggestion 
with glycosidases 
1979; Jennings, 
that it is largely 
due to the heterogeneity of the carbohydrate moiety of the 
molecule (Drickamer, 1978). 
Besides the mediation of anion exchange, other possible 
functions of the protein have been considered. There are 
suggestions that it is also involved in the transport of 
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water (Benz et ~., 1984; Chasan et ~., 1984; Yoon ~ ~., 
1984), sugars (Shelton and Langdon, 1983; Acevedo et al., 
1981), and cations (Solomon et ~., 1983), but so far no 
general agreement seems to exist about their validity. A 
consensus has however developed with regard to sugar 
transport: it is accomplished by the band 4.5 protein 
(Deziel et ~., 1984). Other functions could possibly be 
related to the capacity of the glycoprotein's outward-facing 
carbohydrate moiety to react with lectins (Findlay, 1974; 
Tanner and Anstee, 1976) and its inward-facing N-terminal 
segment to combine with haemoglobin (Salhany et ~., 1980) 
and intracellular enzymes 
Yeltman and Harris, 1980). 
(Strapazon and Steck, 1977; 
There seems to be little doubt 
that it plays an important part in anchoring the constituents 
of the cytoskeleton in the lipid bilayer (Bennett and 
Stenbuck, 1979, 1980; Hargreaves et ~., 1980). These 
observations and the uncertainties about possible additional 
functions explain why the prosaic term "band 3" is usually 
preferred to "anion transport protein" or "capnophorin". 
1.6.2 Structure of band 3 
By proteolytic digestion in situ (Drickamer, 1977) it is 
possible to split the band 3 protein into a number of well-
defined fragments; internal trypsin for example splits off a 
hydrophilic 42 kDa piece (Lepke and Passow, 1976) which is 
released from the membrane (Steck, 1978) while the remaining 
55 kDa piece stays in the bilayer. External trysin produces 
no cleavage. When erythrocytes are treated with external 
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chymotrypsin two fragments of 35 kDa and 60 kDa are formed 
that both remain associated with the membrane. 
The hydrophobic 
fragment that 
55 kDa fragment and 
are obtained after 
the hydrophilic 42 kDa 
cleavage by internal 
trypsin, form 
protein with 
two rather independent domains of the band 3 
different functions (Snow et al., 1981). The 
former is essentially responsible for anion transport and the 
latter for the binding of cytoskeletal proteins and, 
possibly, other intracellular proteins. 
Peptide maps of the 42 kDi water-soluble fragment of band 3 
have been published (Fukuda et ~., 1978) and the amino acid 
sequence of the 201 N-terminal amino acid residues has been 
reported (Kaul et ~., 1983). 
It is noteworthy that in spite of the immense efforts made in 
many competent laboratories, only minor pieces of the amino 
acid sequence of the hydrophobic transport-related domain of 
the band 3 protein have been established. One of the major 
reasons for the slow progress was due to the hydrophobicity 
of many of the cleavage products, which made it difficult to 
separate them from one another • Kopito and Lodish (1985) 
. have however succeeded in isolating eDNA clones of the full 
length of the message for mouse band 3 protein and thus have 
managed to obtain the complete amino acid sequence for murine 
band 3. Analysis of the sequence of this murine band 3 
reveals that the protein possesses 12 membrane-spanning 
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regions, 7 of which form amphipathic helices which could 
cluster around an aqueous "pore". This structure contains a 
gating mechanism, possibly formed by guanidine and carboxyl 
groups, which prevents free diffusion and which catalyses a 
strict one-for-one exchange of anions (Wieth and Brahm, 1985; 
Knauf, 1979). 
A discussion 
modification and 
on the biosyntheis, post-translational 
membrane insertion of band 3 is beyond the 
scope of this thesis. The interested reader is however 
referred to publications from two independent research groups 
(Braell and Lodish, 1981 and 1982; Lodish and Braell, 1982; 
Sabban et al., 1980, 1981; see also a review by Sabatini et 
~., 1982) 
The C-terminal 55 kDa domain of band 3 is anchored in the 
aqueous phase of the outer medium by the carbohydrates that 
are attached to it. The N-terminal end resides in the 
hydrophilic 42 kDa domain which protrudes into the cytoplasm 
at the inner membrane surface; hence, anion transport cannot 
be accomplished by rotational diffusion of the transport 
protein across the lipid bilayer (Passow, 1986). 
Chemical probes which react specifically with the band 3 
protein have afforded much information on the structure and 
function of the anion transport system (for review, see 
Catantchik et al., 1978). Among these probes, stilbene 
disulfonate derivatives have been shown to bind covalently to 
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the membrane-spanning portion of band 3 and competitively 
inhibit self exchange of anions (Grinstein et al., 1978). 
Certain other probes such as NAP-taurine and alpha-cyano-4-
hydroxycinnamate and their analogues, when added outside the 
membrane, interact with an allosterically linked "modifier 
site" (Dalmark, 1976) to cause non-competitive inhibition of 
anion transport (Knauf et al., 1984; Halestrap and Denton, 
1975). These chemical modification studies are regarded as 
indicating that the membrane spanning portion of band 3 forms 
the anion channel and contains a substrate-binding site and a 
modifier site within it. 
1.6.3 Mechanism of anion transport by band 3. 
The single transport site on band 3 is alternating in nature 
and proceeds via a ping-pong mechanism (Gunn and Frohlich, 
1979; Falke and Chan, 1985). It oscillates between two 
different conformations, alternately exposed to opposite 
sides of the membrane, one in which internal (cytoplasmic) 
anions can bind to the transport site, and another in which 
external anions can bind. ihe transport site can only cross 
the membrane when it is occupied by substrate anion; thus 
when an anion gradient is imposed across the membrane the 
transport site accumulates on the side of the membrane 
exposed to 
in another 
low anion concentration (Jennings, 1982). Said 
way, a characteristic of the electroneutral 
exchange mediated by band 3 is that flow of an anion from one 
side of the membrane (cis) to the other (trans) is strongly 
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dependent on the presence of transportable anions at the 
trans side (Hoffmann, 1986). 
Using stilbene disulphonates (Knauf et ~., 1977) and studies 
on the temperature (Frohlich et ~., 1983) and pH dependence 
(Knauf et ~., 1983a,b) of the various flux components, Knauf 
(1986) concluded that anion transport across the erythrocyte 
membrane can be dissected into three components, two of which 
are mediated 
not. Band 
by band 3 protein and another that is probably 
3 seems to mediate (1) the physiologically 
important electrically silent anion exchange process 
described above and (2) a relatively insignificant diffusive 
flow that contributes to the small conductance seen. The 
remaining conductance appears to come from a band 3-
independent conductance pathway. 
1.6.4 Anion specificity 
The kinetics of mono- and divalent anion transport are 
similar in many respects. Equilibrium exchange shows 
saturation kinetics with self-inhibition at high substrate 
concentration (Barzilay and Cabantchik, 1979). Both mono-
and divalent anion transport have the same unusually high 
activation enthalpies, and in addition they compete with each 
other for exchange (Schnell et ~., 1977). Finally, a large 
number of inhibitors produce the same fractional inhibition 
of mono- and divalent transport (Ku et al., 1979). 
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Nevertheless, there exist two important differences: (1) The 
rate of transport of divalent anions is many orders of 
magnitude lower than that for monovalent anions and (2) 
differences in pH dependence. Details of these differences 
follow. 
Studies of self-exchange of mono- and divalent anions 
(Passow, 1969; George Fortes, 1977; Brahm, 1986) have not 
only confirmed the selectivity of the erythrocyte membrane 
for anions versus cations but have also demonstrated marked 
differences in the transport rates for various anions. The 
anions can be ranked according to their relative self-
exchange rates as: 
At physiological pH chloride equilibrates with a half-time of 
210 msec at room temperature (Tosteson, 1959; Dalmark, 1975) 
and PO 2 -4 equlibrate with half-times between 
minutes and hours at 37°C (Passow, 1969). The penetration 
rates are not simply related to the relative apparent 
affinities of the anions for the transport system, as 
indicated by the fact that I- is transported about 300 times 
more slowly than Hco 3-, although the apparent affinity of the 
two anions for the transporter is similar (Dalmark ,1976; 
Wieth, 1979). It should be noted that OH- is not included 
in the sequence as recent experiments have shown that this 
anion is not transported by the anion transport system to any 
measurable degree (Wieth et al., 1980). The apparent flux 
of OH- across the membrane is in fact due to the transport of 
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bicarbonate ions which, by entering the Jacobs-Stewart cycle 
(Jacobs and Stewart, 1942) alter the hydroxyl ion 
concentration so that the distribution of hydroxyl ions 
across the membrane equals the distribution of the monovalent 
anions. 
Measurements of pH dependence of mono- and divalent anion 
fluxes have revealed an interesting difference. Whereas the 
flux of divalent anions such as sulphate (Schell et ~., 
1977, 1981) and phosphate (Deuticke, 1973) has a maximum 
between 6.0 and 6.5 and decreases in the range between~6.5 
and 7.5, the flux of monovalent anions such as chloride and 
iodide increases between pH 6.5 and 7.5 and has a broad 
maximum around pH 7.8 (Gunn 1973; Gunn et al., 1973). 
To explain the pH dependent behaviour Gunn (1972, 1973) has 
proposed a model in which the carrier- (band 3) can be 
titrated by hydrogen ions to form monovalent and divalent 
carriers. At high pH values, the carrier is in the 
uncharged form and does not ·carry ions. Titration of the 
medium from pH 9.5 to 7.8 causes an increasing number of 
monovalent anion carriers to be formed, and the flux of 
monovalent anions across the membrane increases accordingly. 
If the pH is lowered past 7.4, the monovalent carriers are 
converted into divalent ca~~iers; monovalent anion flux 
decreases and divalent flux increases. Below pH 6.5 the 
carrie~ is titrated to the triply charged form which does not 
carry anions. Triply charged anions (e.g. citrate) are 
non-erythroid cells contain much less band 3 than is p~esent 
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therefore unable to cross membranes (Passow, 1986). The 
reactions of anions at the interface are considered to be at 
equilibrium, and the rate limiting step is the translocation 
of the neutral carrier-anion complex from one surface to the 
other. It is further assumed that if the monovalent ions 
combine with the divalent carrier, as they appear to do at 
low pH, the complexes formed are translocated very slowly 
(Sachs et ~., 1975). 
There are certain objections to Gunn's mode~ of a titratable 
carrier, the details of which are beyond the scope of this 
overview. The interested reader is however referred to 
Passow's (1986) excellent review article. Suffice it to say 
that to date, Gunn's model is the one which can best explain 
experimental observations, notwithstanding the difficulties 
in interpreting the data of phosphate fluxes: over the 
physiological range there are variations of the ratio between 
monovalent and divalent ions. Runyon and Gunn (1984) and 
Berghout et al. (1985) have reported conflicting observations 
on the flux of monovalent and divalent phosphate ions. 
1.6.5 Transport of organic anions 
Small mono- and divalent organic anions are transported 
across the 
transporter 
erythrocyte 
(the band 
configuration (Deuticke, 
membrane by the general anion 
3 protein) if of the correct 
1973; Knauf, 1979; Nanr i et al. ,. 
1983 and see Motais, 1977 for review). Molecules with a 
carbon chain length greater than four are not transported 
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unless amphiphilic in structure. The rates of transport of 
these organic anions are some hundreds to millions of times 
slower than for chloride and bicarbonate ions; the 
discrepancy being ascribed to differences in size, polarity 
and configuration. 
1.6.6 Anion transport in non-erythroid cells 
There are three general mechanisms by which anions cross 
plasma membranes of vertebrate cells (Hoffmann, 1986): 
( i ) electrodiffusion, which must respond to the 
electrochemical potential of the anion at the two sides of 
the membrane, (2) electroneutral exchange mediated by the 
band 3 protein, and (3) the coupled flow (cotransport) 
systems of anions and cations which can be classified as 
"secondary active" transport systems since they depend on 
electrochemical gradients 
hydrolysis of ATP. 
generated by the enzymatic 
The large amounts of band 3 protein contained in the human 
erythrocyte membrane bestows upon it the capacity to 
transport anions rapidly across 
part, its physiological role. 
Drenckhahn and Zinke (1984) 
its membrane to fulfill, in 
Kay et al. (1983) and 
have demonstrated that 
polypeptides sharing common antigenic determinants with 
erythrocyte band 3 are present in non-erythroid cells, as 
determined by immunofluorescence, immunoelectronmicroscopy 
and immunoautoradiography. It would however appear that 
non-erythroid cells contain much less band 3 than is present 
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in erythrocytes. Furthermore, these polypeptides, which are 
immunologically related to band 3 are mostly in the form of a 
42 kDa breakdown product of band 3 (Kay et ~., 1993) which 
is unable to transport anions in the rapid one-for-one 
exchange fashion mediated by the intact 95 kDa molecule. 
Fibroblast plasma membranes, for example, contain only traces 
of the intact 95 kDa band 3 protein (Drenckhahn et ~., 
1994). Hepatocytes may be a notable exception as Cheng and 
bevy (1990) have demonstrated a 97 kDa anion transport 
protein in rat hepatocytes. 
1.7 TRANSPORT OF PURINES ACROSS THE ERYTHROCYTE MEMBRANE 
Erythrocyte uptake1 of nucleosides and nucleobases can be 
viewed as a two-component system, comprised of symmetrical, 
carrier-mediated, non-concentrative transport2 across the 
cell membrane coupled with simple, irreversible Michaelian 
phosphorylation within the cell (Plagemann and Wohlhueter, 
1990; Wohlhueter and Plagemann, 1990). Most experimental 
results to date are consistent with the independent operation 
of the two steps (Plagemann, 1996). 
Human erythrocytes possess only a single nucl~oside/ 
nucleobase transport system with broad substrate specificity 
(Overgaaard-Hansen and Lassen, 1959; Lassen and Overgaard-
I-;Upt~k;;-d;~~t;~-the total intracellular accumulation of 
radioactivity from exogenous substrate regardless of 
metabolic conversions. 
2 
"Transport" denotes the transfer of unmodified substrate 
across the cell membrane as mediated by a saturable 
selective carrier. 
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Hansen, 1962a; Lassen and Overgaard-Hansen, 1962b;. 01 i ver 
and Paterson, 1971; Cass and Paterson, 1972, 1973). 
Working with monolayer cultures of non-proliferating rabbit 
polymorphonuclear leukocytes, Taube and Berlin (1972) found 
that these cells also possessed a single nucleoside transport 
system. Plagemann and Richey (1974) however, found several 
nucleoside transport systems in cultured animal. cells and 
whether or not several nucleoside transport systems operate 
in non-erythroid cells has not yet been finally settled 
(Plagemann et al., 1985a and b). 
The transport of nucleosides/nucleobases across the 
erythrocyte membrane is facilitated by both saturable and 
non-saturable carrier systems (Lassen, 1967) and is rapid, 
equilibrium being reached within a minute, even at millimolar 
concentrations (Lassen, 1967; Plagemai'm and Wohlhuet.er, 
1980). Until recently, the transport process was thought to 
be by facilitated diffusion and not energy dependent 
(Plagemann and Wohlhueter, 1980). However, i~ has recently 
come to light that there is a second nucleoside transport 
system which is concentrative and sodium-dependent (Jakobs 
and Paterson, 1986; Vijayalakshmi and Belt, 1988). 
1.8 ERYTHROCYTE PURINE METABOLISM 
Figure 1.3 serves as a focus for this section. 
The purine nucleotides of mature mammalian erythrocytes 
. ) 
undergo turnover as shown by incubation studies carried out 
by a number of authors (Lowy et al., 1960; Bishop et al., 
1959), as well as by in vivo studies (Lowy et al., 1958; 
Bishop, 1961; Hager et al., 1966). So-called de novo 
synthesis of purines does not appear to take place in mature 
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Figure 1.3. Outline of purine metabolism in the erythrocyte. 
ADA, adenosine deaminase; APRT, adenosine phosphoribosyl 
transferase; HGPRT, hypoxanthine-guanine phosphoribosyl 
transferase; S'NT, purine 5'-nucleotidase; PK, purine kinase; 
PNP, purine nucleoside phosphorylase; XO, xanthine oxidase 
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human erythrocytes because one of the enzymes of the last 
portion of the de novo pathway (adenylosuccinate synthetase) 
is not present in these cells (Lowy et al., 1962). 
(Adenylosuccinase, another enzyme in the terminal part of the 
de ~ pathway, was also believed to be absent in mature 
human erythrocytes (Lowy et al., 1962), but Jaeken and Van 
den Berghe (1984) have subsequently demonstrated its 
' presence.) However, the rabbit erythrocyte does have the 
enzymes of the last portion of the de ~ pathway (Lowy et 
al., 1960, 1961a, 1961b). This allows the rabbit 
erythrocyte to use the adenine (and guanine) precursor, 5-
amino-1-ribosyl-4-imidazole carboxamide. Preiss and Handler 
(1958), Zeitlin-Beck et al. (1964), Soshani et ~· (1965) and 
Hager et al. (1966) have shown that the· nucieotide 
derivatives of adenine, guanine and hypoxanthine each exhibit 
a different and characteristic rate of renewal via a highly 
efficient salvage mechanism which uses the preformed purines 
as nucleotide precursors. 
It is noteworthy that the biological half-life of adenine is 
about ten-fold longer in human than in rabbit erythrocytes 
(Zeitlin-Beck et al., 1964), notwithstanding the essential 
similarity in the overall patterns of purine turnover 
displayed by these cells. It appears likely that this 
disparity between the erythrocytes of the two species is 
inherent in the different extent of contribution of exogenous 
purines to their adenine pools, as determined by the capacity 
for converting hypoxanthine to adenine which is negligible in 
the human and s~bstantial in rabbit erythrocytes (Lowy et 
.!..!.•, 1961a; Hershko et !.!.·, 1963; Lowy et ~·, 1962). 
The unique 
erythrocyte 
status of 
purines 
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hypoxanthine in 
is reflected 
~' 
the metabolism of 
in its exclusive 
intracellular appearance in the form of IMP, thus differing 
from both adenine and 
cell predominantly 
guanine which 
by their 
are represented in the 
respective nucleoside 
triphosphates (Mager et al., 1966). Hypoxanthine is further 
distinguished by its particularly rapid rate of clearance 
from the erythrocyte, as well as by the low level of its 
normal intracellular pool (Bishop et al., 1959). This 
distinctive behaviour of hypoxanthine is consistent with its 
role both as an end product of the metabolism of purine 
nucleotides in the erythrocyte (Bishop et ~., 1959; Hershko 
et al., 1963), and as a mediator in the postulated two way 
traffic of purines between the liver and peripheral tissues, 
in which the erythrocyte may serve as the transp~rting 
vehicle (Henderson and Le Page, 1959; Zeitlin-Beck, 1964; 
Soshani et ~., 1965; Murray, 1971; Pritchard et al., 1975; 
Fox and Kelley, 1978). The turnover of adenine nucleotides 
in erythrocytes can proceed via two pathways; both of which 
IMP Inosine Hypoxanthine yield hypoxanthine: 
and AMP Adenosine 
1985b), but 
AMP 
Inosine 
the extent 
Hypoxanthine (Plagemann 
to which these function in 
erythrocytes in the body and might be influenced by 0 2 
tension (see discussion in Chapter 2) and aging of the cells 
is unclear. Any adenosine that is generated in the second 
pathway might be rapidly rephosphorylated, except perhaps in 
aging cells, but the hypoxanthine that is formed will be 
released, because of the limited capacity of the cells to 
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phosphoribosylate it at physiological phosphate concen-
trations. Hypoxanthine may be the main purine source for 
other body cells which exhibit a greater salvage capacity 
than erythrocytes under these conditions. 
In view of the absence of de ~ synthesis, the mechanism by 
which the human erythrocyte turns over its adenine 
nucleotides is not completely clear. By examining Fig. 1.3 
one can see that AMP can be synthesized from adenine through 
the action of APRT and PRPP, or from adenosine via adenosine 
kinase and ATP. The synthesis of PRPP in the erythrocyte 
has been discussed in section 1.5. 
Adenine is not detectable in the plasma of normal humans 
(Brewer, 1974). Henderson and Le Page (1959) have suggested 
that as the erythrocyte passes through the liver it picks up 
adenine, perhaps with such avidity that detectable levels are 
not seen in peripheral blood. The addition of adenine to 
blood before storage has been shown to be beneficial in terms 
of maintaining ATP levels and improving the survival of long-
stored erythrocytes after transfusion (Brewer, 1974). It is 
likely that this benefit accrues fro~ the adenine-
facilitating synthesis of new adenine nucleotide. Plagemann 
(1986), however, has shown that adenine is probably of little 
I 
I 
use to erythrocytes because it is poorly salvaged under 
physiological conditions. 
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Meyskens and Williams (1971) make a case for an important 
role for adenosine and adenosine kinase in the synthesis of 
AMP in human erythrocytes They point out that uric acid 
production is normal in patients with APRT deficiency, which 
suggests that this route is not too important for adenine 
nucleotide synthesis, at least at the whole body level. 
Meyskens and Williams (1971) provide kinetic data for 
adenosine kinase and outline mechanisms for its possible 
regulation of adenine nucleotide synthesis. This view is 
supported by Plagemann (1986) who found that adenosine is the 
main purine source for salvage in the human erythrocyte. 
Again, a source of adenosine is required and Lowy and Lerner 
(1974) and Pritchard et al. (1975) have demonstrated a role 
for liver adenosine in the renewal of the adenine nucleotides 
in human and rabbit erythrocytes. 
Since ATP is involved in various aspects of glycolytic 
regulation in the red cell, the mechanisms by which adenine 
or adenosine is provided to the circulating erythrocyte are 
of considerable interest. That is, it seems possible that 
the availability of these substances, if they are normally 
supplied exogenously to the cell, could have an important 
role in determining the level of erythrocyte ATP as has been 
suggested by Syllm-Rapaport et al., (1969) for adenine. 
Increases in ATP might result from increased availability of 
adenine or adenosine and would be expected to activate 
hexokinase and possibly to inhibit phosphofructokinase. In 
3 1 
this manner, the exogenously supplied purines could play an 
important role in regulating overall glycolysis. 
The nucleoside inosine has an effect upon erythrocyte 
metabolism but does not appear to contribute to AMP synthesis 
in the mature erythrocyte (Brewer, 1974). Inosine can 
penetrate the erythrocyte membrane and is then converted to 
ribose-1-phosphate and hypoxanthine by purine nucleoside 
phosphorylase. The ri.bose-1-phosphate is converted to 
ribose-5-phosphate which then enters the pentose phosphate 
shunt and provides substrate which re-enters the EMP in the 
usual manner. In this way phosphorylated substrate is 
obtained, bypassing the hexokinase and phosphofructokinase 
reactions· (Fig. 1 .1) • With the use of inosine it is 
possible to increase substrate flow into the glycolytic 
pathway both in vitro and in vivo. However, the buildup of 
2,~-DPG and ATP by inosine alone is not nearly as great as 
with the use of inosine and Pi together (Sugerman et al., 
1972). In the absence of Pi there is an accumulation of 
fructose-1,6-bisphosphate, dihydroxyacetone phosphate and 
glyceraldehyde-3-phosphate which probably indicates a lack of 
Pi at the glyceraldehyde-3-phosphate dehydrogenase step. 
With the addition of Pi, substrate flows down to the lower 
part of the pathway and 2,3-DPG levels, and to a certain 
extent ATP levels, are increased. These effects can be 
increased even further by the addition of pyruvate which 
apparently generates additional NAD by reversing the lactate 
dehydrogenase reaction (Sugerman et ~., 1972). The NAD is 
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required at the glyceraldehyde-3-phosphate dehydrogenase 
step. Inosine has been found to be particularly effective 
in rejuvenating blood after prolonged storage in which ATP 
has reached quite low levels (Brewer, 1974). Owing to the 
low levels of ATP, phosphorylation of glucose by hexokinase 
is ineffective and inosine provides substrate without using 
this step, as pointed out above. Unfortunately, inosine is 
also degraded to uric acid which creates a limitation for its 
use in man. In addition to possible synthesis of AMP, 
adenosine is converted to inosine by adenosine deaminase. 
Such inosine can then be utilized in the manner described 
above. 
The human erythrocyte is capable of converting hypoxanthine 
or guanine to IMP or GMP respectively, with PRPP as a 
cofactor; the enzyme hypoxanthine-guanine phosphoribosyl 
transferase (HPRT) catalyses these reactions. HPRT is the 
enzyme that is deficient in the Lesch-Nyhan syndrom~, a sex-
linked disease characterised by hyperuricaemia, 
mutilation, choreoathetosis, spasticity and 
self-
mental 
retardation (Seegmiller et ~., 1967). The presence of the 
enzyme in the erythrocyte makes it a convenient tissue with 
which to make the diagnosis. Inosinic acid dehydrogenase 
links inosine metabolism with guanine nucleotide metabolism 
(Pehlke et al., 1972) and its activity is increased in the 
Lesch-Nyhan syndrome. 
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Both guanine kinase and nucleoside diphosphokinase, 
additional enzymes of guanine nucleotide metabolism, are 
present in the human erythrocyte (Agarwal et ~., 1971). So 
far, no specific function for GTP and other guanosine 
nucleotides in the erythrocyte have been identified (Brewer, 
1974). 
An enzyme called inosine triphosphatase is present in the 
erythrocyte (Liakopoulo and Alivasatos, 1964), and an 
autosomally inherited deficiency of the enzyme has been 
described (Vanderheiden, 
individuals, elevated 
1.969). 
levels 
In 
of 
homozygous affected 
ITP accumulate in 
erythrocytes. 
(Brewer 1974). 
The functions of ITP and ITPase are unknown 
1.9 2,3-BISPHOSPHOGLYCERATE 
1.9.1 Introduction 
In recent years 2,3-bisphosphoglycerate (2,3-DPG) has been 
recognised as a regulatory molecule involved in the control 
of metabolism and other cellular functions. It is widely 
present in living cells, functioning as a co-factor for the 
enzyme phosphoglycerate mutase. Human and many other 
mammalian erythrocytes contain 2,3-DPG in much higher 
concentrations than are required for phosphoglycerate mutase 
activity. It is now generally accepted that 2,3-DPG serves 
as an important allosteric regulator of haemoglobin function 
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(Duhm and Gerlach, 1974; Duhm, 
Sasaki, 1978; Sasaki et al., 1982; 
1975a and b; Chiba and 
Black et al., 1985). 
2,3-DPG, like cyclic nucleotides, is formed from readily 
available molecules, but is not itself part of a major 
metabolic pathway. . It is neither a biosynthetic precursor 
nor an intermediate in energy metabolism. 
concentration can be independently controlled. 
Hence, its 
In view of its importance, great efforts have been made to 
clarify the functions and metabolism of 2,3-DPG in human 
erythrocytes. A large number of papers on these topics have 
been published, and consequently this review deals with only 
some of the more pertinent findings and implications, the 
purpose being to summarise the various asp~cts of 2,3-DPG 
metabolism which are related to changes of 2,3-DPG 
concentrations as well as to the concomitant alterations of 
the oxygen affinity of haemoglobin. 
1.9.2 Historical remarks 
In 1925 Greenwald reported that a major component of organic 
phosphates in human, pig and dog erythrocytes was 2,3-DPG. 
Subsequently, Rapaport and Guest (1941) demonstrated that 
this held for most other mammalian erythrocytes with 
exceptions such as ruminants. In 1949, Sutherland et ~., 
(1949a and b) found a physiological function of 2,3-DPG: to 
act as an essential cofactor in the reaction catalysed by 
phosphoglycerate mutase from animals. The 2,3-DPG level in 
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many mammalian erythrocytes, however, exceeds by more than 
two orders of magnitude that needed for maximal activity of 
phosphoglycerate (Duhm and Gerlach, 1974). This compound 
can therefore be expected to participate not only in the 
phosphoglycerate mutase reaction but also in other 
biochemical events. 
In the history of haemoglobin research, data sufficient to 
explain the physiological significance of these high 2,3-DPG 
concentrations can be found. In 1909, Barcroft and coworkers. 
(Barcroft and Camis, 1909; Barcroft and Roberts, 1909) 
reported that the oxygen affinity of haemoglobin increased 
when erythrocytes were diluted by haemolysis, and as early as 
1921 Adair et al. speculated on the presence of a third 
substance involved in the formation of the oxygen-haemoglobin 
complex. Hill and Wolvekamp (1936) demonstrated that the 
dialysable material from fresh erythrocytes decreased the 
affinity of haemoglobin for oxygen. It is surprising that 
after Greenwald's discovery of 2,3-DPG in erythrocytes in 
1925 more than 40 years passed before its effect on the 
oxygen affinity of haemoglobin was examined. Almost 
simultaneously, Benesch and Benesch (1967) and Chanutin and 
Curnish (1967) reported that 2,3-DPG lowered the oxygen 
affinity of haemoglobin. Their findings, together with 
evidence in subsequent papers, have established that 2,3-DPG 
functions as an effector to facilitate the release of oxygen 
from oxygenated haemoglobin to tissues. 
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1.9.3 Enzymes involved in the metabolism of 2,3-DPG 
Simplified pathways of glycolysis and of phosphoglycerate 
metabolism are shown in Figure 1.4. A more detailed pathway 
for phosphoglycerate metabolism is given in Figure 1.5. 
1,3-DPG, which is an intermediate of glycolysis, can be 
converted to 3-phosphoglycerate (3-PG) in two ways. In most 
tissues it is converted to 3-PG directly in the 
phosphoglycerate kinase reaction. Only in the erythrocyte 
is 1,3-DPG metabolised to a significant extent by 1,3-DPG 
mutase; 2,3-DPG is then metabolised to 3-PG and inorganic 
phosphate (Pi) by 2,3-0PG phosphatase. One important 
difference of the two pathways of 1,3-DPG metabolism concerns 
the fact that the phosphoglycerate kinase (PGK) reaction 
yields one high energy phosphate bond in the form of ATP, 
whereas in the 2,3-DPG bypass, the chemical energy of the 
acyl phosphate group of 1,3-DPG is dissipated. 
The enzymatic reactions implicated in the synthesis and 
breakdown of 2,3-DPG (Figure 1.5) were first described by 
Rapoport and Luebering (1950 and 1951). Originally they 
were attributed to different enzymes: 
A) diphosphoglycerate mutase (EC 5.4.2.4), glycerate 3-P + 
glycerate 1,3-P2 ----••~ glycerate 2,3-P2 + glycerate 3-P; 
and 
B) diphosphoglycerate phosphatase (EC 3.1.3.13), 
glycerate 2,3-P2 ----••~ glycerate 3-P + Pi. 
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Figure 1.4. Pathways of glycolysis and of phosphoglycerate 
metabolism in human erythrocytes and factors influencing the 
formation and decomposition of 2,3-DPG (Duhm and Gerlach, 
1974). See Fig. 1.1 for abbreviations. 
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Figure 1.6. Pathway of 2,3-DPG metabolism. 
Glucose 
3-P-Glycerate 
2-P-Glycerate 
Lactate 
1) 2,3-DPG synthase bisphosphoglycerate mutase, 
EC 6.4.2.4). 
glycerate 3-P + glycerate 1,3-P2 • 
glycerate 2,3-P2 + glycerate 3-P. 
2) 2,3-DPG phosphatase bisphosphoglycerate phosphatase, 
EC 3 • 1. 3 • 13 ) • 
glycerate 2, 3-P2 ___.. glycerate 3-P + Pi 
3) 2,3-DPG-dependent phosphoglycerate mutase (EC 6.4.2.1) 
glycerate 3-P 2,3-DPG• glycerate 2-P. 
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However, it was found (Chiba and Sasaki, 1978; Sasaki et 
al., 1982; Rose, 1980) that in mammalian erythrocytes 
enzymes exist which possess both diphosphoglycerate mutase 
(2,3-DPG synthase) and diphosphoglycerate phosphatase (2,3-
DPG phosphatase) activities. Eight enzyme forms which can 
be involved in the metabolism of 2,3-DPG have been isolated 
from tissues in the pig (Carreras et ~., 1986). Six of 
them are multifunctional enzymes which show 2,3-
bisphosphoglycerate synthase, 2,3-bisphosphoglycerate 
phosphatase and phosphoglycerate mutase activities. They 
differ in their functional and physical properties. The two 
other enzymes isolated from mammalian tissues possess only 
2,3-DPG phosphatase activity. 
Since distribution of the eight enzymatic forms varies in 
different tissues, their relative contribution to the 
synthesis and degradation of 2,3-DPG differs with the tissue 
(Carreras et ~., 1986). In human erythrocytes and in the 
erythrocytes of other mammals with high 2,3-DPG levels, both 
synthesis and breakdown of 2,3-DPG are mainly controlled by 
2,3-DPG synthase-phosphatase. In contrast, in other cells 
the synthesis and degradation of 2,3-DPG involves different 
enzymes (Carreras et al., 1986). Cat erythrocytes possess 
low levels of 2,3-DPG. In these cells, 2,3-DPG synthase-
phosphatase is present at very low concentration and 
phosphoglycerate mutase is the enzyme mainly responsible for 
both synthesis and breakdown of 2,3-DPG (Pons et ~., 1985). 
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1.9.4 Factors controlling 2,3-DPG levels in erythrocytes 
The actual size of the 2,3-DPG pool in erythrocytes is 
' 
determined by the dynamic equilibrium between synthesis and 
degradation. Judging from the 2,3-DPG mutase activity in 
haemolysates, human erythrocytes can maximally synthesise 
about 200 ~moles of 2,3-DPG per hour per millilitre of packed 
cells (Sasaki et ~., 1975). 2,3-DPG phosphatase has the 
lowest activity of all the enzymes connected with glycolysis 
in human erythrocytes, but it is activated by several anions. 
Rose and Liebowitz (1970a) reported that the velocity of the 
enzyme activity in the absence of activators was 0.06 ~mole 
per hour per millilitre of packed cells and the maximal 
activity in the presence of physiological activators was 0.94 
~mole per hour per millilitre of packed cells. 
Human erythrocytes consume 2-3 ~moles of glucose per hour per 
millilitre of packed cells at 37°C and pH 7.4. The share of 
the 2,3-DPG bypass has been estimated to be 15-25% of the 
overall flux through glycolysis (Duhm et ~., 1969; Hamasaki 
and Minakami, 1972; Rapoport et ~., 1977; Reich, 1969; 
Rose and Liebowitz, 1970a and b). From these values, the 
turnover rate of 2,3-DPG can be calculated to be 0.3 - 0.75 
~moles/hr/ml packed erythrocytes. The DPG mutase activity 
in erythrocytes therefore appears to be partially latent, 
whereas 2,3-DPG phosphatase works almost maximally. The 
kinetic data available for considering regulatory mechanisms 
of DPG mutase and 2,3-DPG phosphatase are in large part due 
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to the efforts of Rose and co-workers (Rose, 1968 and 1973; 
Rose and Liebowitz, 1970a; Rose and Dube, 1976). 
1.9.4.1 2,3-DPG synthesis 
The rate of 2,3-DPG synthesis in erythrocytes first of all 
depends on the concentration of 1,3-DPG, since under normal 
conditions the ,concentration of 1,3-DPG is smaller than the 
Km value of DPG mutase (0.5 micromolar) (Rose, 1968). 
Additional factors directly involved in the regulation of 
2,3-DPG synthesis are the concentration of 2,3-DPG itself and 
the concentrations of 3-PG and inorganic phosphate (Rose, 
1968 and 1970; Minakami and Yoshikawa, 1965 and 1966a and b; 
Tuboi and Fukunaga, 1965). 
The concentratibn of 1,!-DPG is governed by the concerted 
action of several glycolytic enzymes (Figure 1.4: 
1. Phosphofructokinase (PFK). 
control the main rate-limiting 
activation of PFK, which can be 
This enzyme is known to 
step of glycolysis. The 
induced by many factors 
(e.g., elevation of pH, increase in Pi, ADP or AMP, decrease 
of ATP) (Passaneau and Lowry, 1964; Rapoport, 1968) must 
therefore lead to increased formation of 1,3-DPG. 
2. Glyceraldehyde-3-phosphate dehydrogenase (GAPO). This 
enzyme can become rate-limiting under certain conditions, 
e.g., at elevated pH and a diminished ratio of NAD: NADH 
(Rapoport, 1968). Pyruvate and methylene blue (oxidised) 
are able to induce an increase in the NAD:NADH ratio and thus 
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promote an increase in 1,3-DPG levels (Rose and Warms, 1970). 
An increase in Pi will also result in increased formation of 
1,3-DPG. 
3. Phosphoglycerate kinase 
enzyme causes an accumulation 
(PGK). Inhibition 
of 1,3-DPG. Since 
of this 
ATP, ADP 
and 3-PG are near to thermodynamic equilibrium with 1,3-DPG 
concentration, changes in each of these compounds must be 
reflected in changes in 1,3-DPG levels 
1974). 
(Duhm and Gerlach, 
4. Pyruvate kinase (PK). A decrease in the activity of 
this enzyme can result in a fall in the ratio of ATP:ADP and 
an elevation of phosphoenol pyruvate (PEP), 2-PG and 3-PG 
levels, since the enolase and the phospholgycerate mutase 
reactions are close to thermodynamic equilibrium (Minakami 
and Yoshikawa, 1966a and b). Because such alterations 
concern the reactants of the PGK reaction, 1,3-DPG levels 
must increase after inhibition of pyruvate kinase (Duhm and 
Gerlach, 1974). 
5. 2,3-DPG mutase. The rate of 2,3-DPG synthesis depends 
not only on 1,3-DPG concentration but also on the level of 
2,3-DPG. DPG mutase is strongly inhibited by its product 
2,3-DPG (Ki = 0.8 ~M) (Rapoport and Luebering, 1952; Rose, 
1968). At physiological levels of 2,3-DPG, the inhibition 
amounts to about 99% (Gerlach and Duhm, 1972), accordingly, 
DPG mutase is working at only 1% of its potential capacity 
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under physiological conditions. In principle therefore, a 
decrease in 2,3-DPG should cause a relief of the product 
inhibition followed by increased synthesis of 2,3-DPG. ) 
Compared to the importance of 1,3-DPG and 2,3-DPG in the 
regulation of 2,3-DPG synthesis, the influence of 3-PG and 
inorganic phosphate on DPG mutase activity is of minor 
importance (Rose, 1968 and 1970). This is due to the fact 
that under most conditions, changes in the concentrations of 
these compounds are not great enough to induce significant 
alterations in the activity of DPG mutase. An exception 
would be in tissue ischaemia where Pi concentrations may rise 
20 to 30 fold (Radda, 1983; Radda et ~., 1983). 
1.9.4.2 2,3-DPG degradation 
As pointed out, the formation of 2,3-DPG depends strongly on 
the concentration of 1,3-DPG, the substrate of DPG mutase. 
In contrast, there is no such relationship in human 
erythrocytes between substrate (2,3-DPG) concentration and 
the rate •of its degradation because of the low Km value of 
2,3-DPG phosphatase (Km = 1 ~M) (Rose and Liebowitz, 1970a 
and b). It thus appears that changes in the rate of 2,3-DPG 
decomposition can only result from alterations in the 
activity of 2,3-DPG phosphatase. 
Hydrogen ion concentration appears to be of particular 
importance in influencing the activity of 2,3-DPG phosphatase 
(Hashimoto et ~., 1961; Grisolia et al., 1968; Rose, 1969; 
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Sauer et ~., 1968; de 
optimum of this enzyme 
Verdier and Groth, 1973). The pH 
is 6.5 (de Verdier, 1964), thus a 
decrease of the intracellular pH from its normal value of 7.2 
causes an acceleration of 
phosphate is also known 
(Rose, 1970). We shall 
2,3-DPG degradation. 
to activate 2,3-DPG 
see in Chapters 2 
Inorganic 
phosphatase 
and 3 that Pi 
levels in the erythrocyte increase~with a drop in pH. 
Several investigators have studied the effects of inorganic 
sulphur compounds on the activity of 2,3-DPG phosphatase; 
some have been found to activate it and others to inhibit it 
(Duhm and Gerlach, 1974). The inhibitory action of sulphate 
may be of special significance for 2,3-DPG metabolism in 
erythrocytes of uraemic patients, since it is conceivable 
that the increased levels of red cell 2,3-DPG found in this 
condition may at least be partly related to the well-knowri 
elevation of plasma sulphate found in uraemic patients (Duhm 
and Gerlach, 1974). 
It must be emphasised that the activity of 2,3-DPG 
phosphatase is fairly low compared with the activity of DPG 
mutase (in human erythrocytes 0.01 and 3 to 5 ~moles/gm/min 
respectively) (Duhm and Gerlach, 1974; Rose, 1968; 
Rapoport, 1968). 
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1.9.4.3 Pathophysiological conditions which affect 2,3-DPG 
concentration in erythrocytes 
The concentration of 2,3-DPG in erythrocytes changes in vivo 
in a number of physiological and pathological conditions 
(Table 1.1). Most of these changes and the resulting 
displacements of the oxyhaemoglobin dissociation curve 
constitute one among several adaptive processes which 
together are involved in the improvement of the oxygen supply 
to tissues (Mairbaurl et ~., 1986; Duhm and Gerlach, 1974). 
Studies concerning the influence of exercise and training on 
2,3-DPG content of erythrocytes have given divergent results. 
Although some authors have reported an increase in 2,3-DPG 
concentration, others could not confirm these findings (Remes 
1979). Most 
(anaemia, abnormalities 
kinds of acute and chronic hypoxia 
in haemoglobin affinity for oxygen, 
pulmona~y diseases, reduction in alveolar p02 ), as well as 
respiratory or metabolic alkalosis, produce an increase in 
erythrocyte 2,3-DPG. This increase can be attributed to a 
decrease in the free 2,3-DPG concentration due to greater 
binding of the metabolite to deoxyhaemoglobin, and to an 
increase in cellular pH (Benesch and Benesch, 1967 and 1974; 
Benesch et ~., 1968a and b). The decrease in free 2,3-DPG 
would enhance its synthesis by relieving 2,3-DPG synthase 
from product 
2,3-DPG levels 
by stimulating 
inhibition. The increase in pH would elevate 
by increasing glycerate 1,3-P2 concentration 
glycolysis, and by changing the catalytic 
properties of 2,3-DPG synthase-phosphatase, stimulating the 
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TABLE 1.1 
Factors and conditions which affect the level of 2,3-DPG in 
erythrocytes 
Condition 
Exercise 
Hypoxia 
Respiratory and metabolic 
alkalosis 
Abnormalities of glycolytic 
enzymes 
Hepatic cirrhosis 
Kidney diseases 
Neoplastic diseases 
Hyperthyroidism 
Androgens 
I increases 
D decreases 
Effect 
I 
I 
I 
I/D 
I 
I 
I 
I 
I 
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synthase and reducing the phosphatase activity (Duhm and 
Gerlach, 1974; Brewer and Eaton, 1971; Finch and Lenfant, 
1972). Erythrocyte levels of 2,3-DPG rise in patients 
suffering from hepatic cirrhosis, uraemia and other kidney 
diseases, neoplastic and toxic diseases (Duhm and Gerlach, 
1974; Chiba and Sasaki, 1978; De la Morena, 1979 and 1984). 
The factors involved in the changes of 2,3-DPG in these 
diseases are not well understood. 
Congenital abnormalities in erythrocyte glycolytic enzymes 
can alter 2,3-DPG concentration. Rate-limiting enzymatic 
abnormalities of the glycolytic pathway before the stage of 
glycerate 1,3-P2 formation reduce the amount of 2,3-DPG and 
therefore increase oxygen affinity. Alterations located 
after that stage may either increase or decrease 2,3-DPG 
concentration (Finch and Lenfant, 1972). 
It has been found that erythrocyte 2,3-DPG levels increase in 
hyperthyroidism and after incubation of normal blood in the 
presence of thyroid hormones. A correlation has been shown 
between reduction in aldosterone excretion in urine and a 
decrease in erythrocyte 2,3-DPG. It has also been reported 
that androgens increase levels of 2,3-DPG in erythrocytes. 
The underlying mechanisms of these hormonal effects remain 
unclear (Duhm and Gerlach, 
Finch and Lenfant, 1972). 
1974; Chiba and Sasaki, 1978; 
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1.9.4.4 Deficiency of the enzymes implicated in 2,3-DPG 
metabolism 
Deficiencies of two of the multifunctional enzymes involved 
in 2,3-DPG metabolism, 
phosphatase and muscle-type 
erythrocyte 2,3-DPG synthase-
phosphoglycerate mutase, have 
been reported. In 1978, Rosa et al. described a case of an 
inherited and complete deficiency of 2,3-DPG synthase-
phosphatase in human erythrocytes. The level of 2,3-DPG was 
found to be below 3% of normal values. Accordingly, the 
oxygen affinity of the erythrocytes was increased, although 
the oxygen saturation curve 
DPG was normal. 2,3-DPG 
of the haemolysate free of 2,3-
synthase and 2,3-DPG phosphatase 
activities were undetectable, and phosphoglycerate mutase 
activity was about half of the mean normal value. All other 
erythrocyte enzyme activities were normal. It was suggested 
that the small amounts of 2,3-DPG present could have been 
synthesized by phosphoglycerate mutase (Rosa et al., 1978), 
as has been shown to be the case in certain mammalian 
erythrocytes with low levels of 2,3-DPG (Carreras et al., 
1983; Pons et al., 1985). 
Muscle type M phospholgycerate mutase deficiency has recently 
been described in a patient with intolerance for strenuous 
exercise. In agreement with the tissue distribution of the 
type M (muscle) isoenzyme, the levels of phosphoglycerate 
mutase activity were found to be markedly decreased in 
skeletal muscle but only slightly reduced in erythrocytes, 
leukocytes and cultured muscle. The electrophoretic pattern 
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showed that the residual phosphoglycerate mutase activity in 
the patient's muscle corresponded to the brain-type 
isoenzyme, normally present in very small quantities in adult 
muscle (Di Mauro et ~., 1981 and 1982). 
1.9.5 Functions of 2,3-DPG 
Most mammalian erythrocytes possess 2,3-DPG in ·high 
concentration (4-13 mmol/1; humans, 5 mmol/1). Exceptions 
are the erythrocytes of some carnivores and artiodactyles 
which contain low levels (0.1 - 1 mmol/1) (Bunn et al., 1974; 
Vanderheiden, 1961). 2,3-DPG influences many biochemical 
events in the erythrocytes of humans and these influences are 
summarized in Table 1.2. 
1.9.5.1 Effect on oxygen affinity of haemoglobin 
The major role of 2,3-DPG in erythrocytes is to act as an 
allosteric modulator of the affinity of haemoglobin for 
oxygen. Oxygenation of haemoglobin leads to a conformational 
change in its quaternary structure (Wyman, 1964). According 
to the X-ray crystallographic studies of Perutz et ~. (1970) 
the transition from the deoxy- to the oxy- conformation is 
triggered by changes in the diameter of the iron atoms (upon 
oxygenation) in the haem groups which induce alterations of 
the tertiary structure of the subunits. 
It is now well established that 2,3-DPG is preferentially 
bound to deoxyhaemoglobin, whereas the oxy- conformation 
50 
TABLE 1.2 
Possible functions of 2,3-DPG in erythrocytes. 
Ref. Chiba and Sasaki, 1978. 
Primary effect 
Binding to HB 
Participation in 
Donnan distribution 
Interaction with 
enzymes or chelation 
of Mg2+ 
Unknown effect 
Secondary effects 
• Decrease in o2 affinity of Hb 
• Change in Bohr effect 
• Decrease in co 2 binding to Hb 
• Stimulation of gelation of 
deoxygenated sickle cell Hb 
• Change in concentration of free 
ATP, 2,3-DPG and Mg2+ 
• Change in erythrocyte pH 
• Change in o2 affinity of Hb 
• Changes in activities of pH-
dependent enzymes 
• Change in activity of metabolic 
pathways 
• Inhibition of platelet aggregation 
-------~---------------------------------------------------
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exhibits only a low affinity for 2,3-DPG because of a 
different steric arrangement of the binding sites (Benesch et 
al., 1968a and b; Perutz, 1970). Due to the binding of 
2,3-DPG, the deoxy- conformation is stabilized and the 
allosteric equilibrium between the oxy- and deoxy-
conformation 
structure. 
is thereby 
Consequently 
shifted favouring the deoxy-
the 2,3-DPG induced stabilization 
of the deoxy- conformation must lead to a decrease in the 
oxygen affinity of haemoglobin thus facilitating the supply 
of oxygen to tissues (Benesch and Benesch, 1967 and 1974; 
Benesch et al., 1968a and b). From these findings it appears 
that four phenomena are causally related to each other: 1) 
the conformational change of the haemoglobin tetramer during 
oxygenation, 2) the difference in the oxygen affinities of 
the two quaternary conformations, 3) the preferential binding 
of 2,3-DPG to the deoxy- conformation, and 4) the reduction 
of the oxygen affinity of haemoglobin by 2,3-DPG. 
Studies have shown that only one molecule of 2,3-DPG can be 
bound to one deoxyhaemoglobin tetramer and that only isolated 
beta- chains, but not isolated alpha- chains, react with 2,3-
DPG (Benesch et al., 1968a and 1968b). This provided 
evidence for the binding of 2,3-DPG to the beta-chains along 
the "dyad axis of symmetry" of the haemoglobin tetramer. It 
was subsequently demonstrated that 2,3-DPG binds to histidyl 
groups 143 of the beta- chains and to the two N-terminal 
valines of the beta- chains, all of which are directed into a 
central cavity of the tetramer (Duhm and Gerlach, 1974). It 
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has furthermore been demonstrated that co2 reduces the 
binding of 2,3-DPG and its effect on the oxygen affinity of 
haemoglobin by forming carbamate groups with the N-terminal 
values of the beta- and alpha- chains (Bauer and Schroder, 
1972; Duhm and Gerlach, 1974). 
According to Perutz (1970) the 2,3-DPG molecule fits into the 
central cavity of the deoxyhaemoglobin tetramer in such a way 
that the anionic groups of 2,3-DPG are within hydrogen-
bonding distance of the histidyl groups 143 and of the two N-
terminal amino groups of the two beta- chains. The amino 
group of lysine 82 in one beta- chain can also react with 
2,3-DPG. Upon oxygenation, conformational changes are 
induced which result in the central cavity becoming narrower. 
Furthermore, the distance between the two N-terminal amino 
groups of the beta- chains increases and therefore the 
affinity of binding of the 2,3-DPG molecule to both of them 
decreases. Thus 2,3-DPG is released from its binding sites 
during oxygenation of deoxyhaemoglobin. Conversely, the 
preferential binding of 2,3-DPG with deoxyhaemoglobin 
displaces the Hb02 Hb equilibrium to the deoxygenated\ 
form. 
2,3-DPG is not the only compound which reduces the oxygen 
affinity of haemoglobin by differential binding to the oxy-
and deoxy- conformations. Among these compounds ATP 
(Benesch et al., 1986) and phytic acid are of physiological 
importance, whereas GTP, pyridoxal-5-phosphate, hexameta-
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phosphate and a fluorescent analogue of 2,3-DPG as well as 
certain spin labels are of theoretical interest (Duhm and 
Gerlach, 1974). It has been found that those species with 
high levels of erythrocyte 2,3-DPG possess haemoglobins of 
intrinsically high oxygen affinity. In contrast, those 
species with low levels of erythrocyte 2,3-DPG possess 
haemoglobins with relatively low oxygen affinity and which 
are unresponsive to 2,3-DPG. Thus, the level of 2,3-DPG in 
each species is appropriate for the functional capability of 
its haemoglobin (Bunn et ~., 1974). During embryonic and 
foetal development a shift in the type of synthesized 
haemoglobin occurs, 
affinity appearing. 
haemoglobins with different oxygen 
The concentration of 2,3-DPG in 
erythrocytes during development varies in the appropriate way 
to keep the oxygen affinity of the foetal red cells higher 
than that of the maternal red cells, and to ensure oxygen 
transport across the placenta (Chiba and Sasaki, 
Sasaki et ~., 1982). 
1.9.5.2 Control of Glycolysis 
1978; 
The rate of glycolysis in human erythrocytes is about one-
fifth the maximal activity of hexokinase, which has the 
lowest activity of all the glycolytic enzymes (Jacobasch et 
al., 1974; Bishop, 1964). Thus the glycolytic enzymes are 
not saturated by their substrates, whose concentrations are 
regulated mainly by three enzymes, hexokinase, phospho-
fructokinase and pyruvate kinase. These key enzymes are 
primarily responsible for the regulation of glycolysis in 
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human erythrocytes because the reactions they catalyze are 
far from thermodynamic equilibrium (Minakami and Yoshikawa, 
1966a). The activities of these enzymes are controlled by 
substrates, cofactors and effectors, including 2,3-DPG. 
Duhm (197Sb) prepared erythrocytes containing five times the 
normal amount of 2,3-DPG and 'found that the glucose 
consumption and lactate production rates in such cells were 
reduced by 70% and 40% respectively, compared to those of 
normal cells. About SO% of the inhibition of glycolysis in 
"high 2,3-DPG" cells was attributed to direct inhibitory 
effects of 2,3-DPG on hexokinase and pyruvate kinase, and the 
remaining SO% to a reduction in phosphofructokinase activity 
caused by a 2,3-DPG-induced decrease in intracellular pH. 
1.9.S.3 Other functions 
In addition to decreasing the affinity of haemoglobin for 
oxygen and its role in the control of glycolysis, several 
other functions have been postulated for 2,3-DPG in mammalian 
erythrocytes. 
several actions: 
By binding to haemoglobin, 2,3-DPG has 
it influences the effect of pH on the 
oxygenation curve of haemoglobin (the Bohr effect), decreases 
co 2 binding to haemoglobin, has a biphasic influence on the 
tetramer-dimer equilibrium of carbon monoxide haemoglobin 
(Gray and Dean, 1987), changes the concentration of free ATP 
and Mg 2 +, and 
ascorbate (Duhm 
stimulates methaemoglobin reduction by 
and Gerlach, 1974; Chiba and Sasaki, 1978). 
The role that 2,3-DPG has to play in erythrocyte purine 
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metabolism is discussed in Chapter 2. 2,3-DPG can develop 
other functions not related to haemoglobin binding. By 
interacting with 
deformability of 
cytoskeleton proteins, it may influence the 
the red cell membrane and the lateral 
mobility of integral membrane proteins (Sheetz and Casaly, 
1981; Mentzer et !!•, 1987). By interacting with the 
transport system, 
phosphoenolpyruvate 
(Hamasaki, 1984). 
establishment of a 
it may inhibit the transport of 
across the erythrocyte membrane 
Through its participation in the 
Donnan distribution of hydrogen ions 
between erythrocytes and plasma, 2,3-DPG can affect the 
oxygen affinity of haemoglobin as well as the activity of 
several enzymes (Chiba and Sasaki, 1978). 2,3-DPG may also 
affect enzyme activity by either chelating Mg 2 + or 
interacting directly with the enzymes (Chiba and Sasaki, 
1978). It has been shown that at physiological 
concentrations 2,3-DPG inhibits several enzymes involved in 
carbohydrate and adenine nucleotide metabolism (Table 1.3), 
although it has not been shown that all these effects are 
important in the regulation of the metabolic pathways in 
erythroid cells (Chiba and Sasaki, 1978). 
It has recently been shown that, by binding at the substrate 
binding site, 2,3-DPG can act both as an activator and an 
inhibitor of casein kinase II from rabbit reticulocytes 
(Hathaway and Traugh, 1984a and b). On this basis it has 
been suggested that intracellular fluctuations in the levels 
of 2,3-DPG could regulate casein kinase II activity in 
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TABLE 1.3 
Effects of 2,3-DPG on Enzyme Activities 
Enzyme Source .Effect 
I Hexokinase 
Phosphofructokinase 
Pyruvate kinase 
Phosphoglycerate kinase 
2,3-DPG synthase 
Glyceraldehyde 3-P dehydrogenase 
Aldolase 
Phosphoglucomutase 
G-1,6-P2 synthase 
6-Phosphogluconate dehydrogenase 
Transaldolase 
Transketolase 
AMP deaminase 
HPRT 
APRT 
PRPP synthetase 
Purine 5'-nucleotidase 
Casein kinase II 
E 
E,H,B 
E 
E 
E,H 
E,H 
E 
E,H,L 
H,B 
E 
E 
E 
E,H 
E 
E 
E 
E 
R 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
A 
I/A 
Key: E: erythrocytes; H: skeletal muscle; H: heart; 8: 
brain; L: liver; R: rabbit erythrocytes. 
activation; I: inhibition. 
Effects: A: 
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·erythroid cells and thus influence protein synthesis and 
other cellular functions (Hathaway and Traugh, 1984a). 
Inhibition of protein synthesis by 2,3-0PG in rabbit 
reticulocyte lysates has already been reported (Narita et 
al., 1979). 
In cells. other than erythrocytes the only known function for 
2,3-DPG is to act .as an essential cofactor in the 
interconversion of glycerate-3-P and glycerate-2-P catalysed 
by the 2,3-0PG dependent phosphoglycerate mutase (EC 5.4.2.1) 
(Grisolia, 1968). the physiological significance of the 
inhibitory effect of 2,3-DPG on several enzymes demonstrated 
in vitro is uncertain, because there is not sufficient 
information about the concentration of 2,3-DPG in tissues. 
Due to blood contamination, the concentration of 2,3-DPG in 
mammalian tissues has not been estimated accurately (Chiba 
and Sasaki, 1978). In rat tissues Carreras et al. (1986) 
have detected levels ranging from 0.25 nmol/g wet tissue in 
brain to 41 nmol/g in liver. 
I 
( 
.... 
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CHAPTER 2 
AN OXYPURINE CYCLE IN HUMAN ERYTHROCYTES REGULATED BY pH, 
INORGANIC PHOSPHATE,· AND OXYGEN 
2.1 INTRODUCTION 
De novo purine synthesis does not take place in mature 
erythrocytes (Lowy et al., 1962), whereas formation of purine 
nucleotides by salvage pathways and release as purine bases 
has long been known to occur (Mager et ~., 1966; Hershko et 
li·, 1967; Hershko et ~., 1969). It is sometimes stated 
that this may represent a role for the erythrocyte in the 
transport of purines from tissues with a purine surplus ~o 
tissues with a purine requirement (Henderson and Le Page, 
1959; Lowy and Lerner, 1974). 
Human erythrocytes can take up and convert to the 
corresponding nucleotide a number of purines including 
adenine, adenosine, hypoxanthine and guanine (Mager et al., 
1966; Gutenson, 1975). Mager et al. (1966) have pointed 
out that unlike other purine base substrates, which 
contribute to di- and triphosphate nucleotide pools, 
anabolism of hypoxanthine ceases at inosine 5'-monophosphate 
(IMP). Hypoxanthine is further distinguished by its 
particularly rapid rate of clearance from erythrocytes as 
well as the negligible size of its normal intracellular pool 
(Bishop et al., 1959). This distinctive pattern of 
metabolism of hypoxanthine is consistent with its role both 
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as an end product of purine catabolism in the human 
\ 
erythrocyte (Bishop et ~., 1959; Hershko et ~., 1963; 
Schraufstatter and Born, 1981) and as a mediator in the 
postulated two-way traffic of purines between the liver and 
peripheral tissues (at least 95% of the hypoxanthine pool is 
recycled), in which the erythrocyte may serve as the 
transporting vehicle (Henderson and Le Page, 1959; Zeitlin-
Beck et ~., 1964; Soshani et !!•, 1965). 
Hypoxanthine is transported rapidly across the red cell 
membrane by both saturable and non-saturable carrier systems 
(Lassen, 1967). In this respect erythrocytes differ from 
cultured nucleated cells which possess only the saturable 
system (Harz et al., 1979). Equilibrium is reached within a 
minute even at millimolar concentrations of hypoxanthine in 
the medium (Lassen, 1967). Initially it was reported that 
in erythrocytes from fresh heparinised blood little or no 
conversion of hypoxanthine to IMP occurred (Lowy et al., 
1962; Bishop et ~., 1959). Later it was found that 
whereas this appeared to be generally correct for freshly 
drawn blood, where the physiological concentration of Pi in 
plasma is around 1 mH, if the erythrocytes were incubated in 
medium containing higher levels of inorganic phosphate (Hager 
et _al., 1966; Hershko et al., 1969; Gutenson, 1975; 
Giacomello and Salerno, 1979) there was conversion of 
hypoxanthine to IMP with an optimum external inorganic 
phosphate concentration of around 20 to 30 mH (Hager et al., 
1966; · Gutenson, 1975). 
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Hershko et ~· (1969) have demonstrated that synthesis of 5-
phosphoribosyl-1-pyrophosphate (PRPP) in erythrocytes follows 
sigmoid kinetics with respect to inorganic phosphate. At 
neutral pH the rate of synthesis was negligible at external 
inorganic phosphate concentrations below 5 mM, but showed 
progressive enhancement with increasing external inorganic 
phosphate, reaching levels approaching 100 nanomoles/ml 
cells/hr at external inorganic phosphate concentrations of 30 
mM. It is now generally accepted that the limiting factor 
in the ability of erythrocytes to synthesize IMP from 
hypoxanthine is the availability of PRPP (Hershko et al., 
1969; Henderson and Le Page, 1959; Giacomello and Salerno, 
1979). PRPP synthetase is inhibited by ADP, GOP and 2,3-
bisphosphoglycerate (2,3-DPG) and stimulated by inorganic 
phosphate (Fox and Kelley, 1971a and b). Even under 
experimental conditions of high external inorganic phosphate 
concentrations the synthesis of PRPP amounts to only 1% of 
the rate observed in equivalent amounts of stroma-free 
haemolysate (Hershko et ~., 1969) and has been attributed to 
allosteric inhibition by ADP and 2,3-DPG (Hershko et ~., 
1969; Sciaky et ~., 1974). 
Little quantitative information has been published on the 
effect of pH on IMP formation or degradation in erythrocytes. 
Salerno et al. (1986) have reported that incorporation of 
hypoxanthine into IMP increased with decreasing pH whereas 
Schraufstatter and 
independent of pH. 
Born (1981) reported that this was 
The latter did, however, report that 
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hypoxanthine and some inosine were released from erythrocytes 
labelled with 3H-Adenine or 3M-Adenosine at an accelerated 
rate at alkaline pH values. Bontemps et al. (1986) reported 
that alkalinisation of the incubation medium resulted in a 
fifteen-fold increase in the rate of production of 
hypoxanthine from erythrocytes. Uraemic subjects (who are 
well known to be acidotic and to have raised serum phosphat~ 
levels) were noted to have raised erythrocyte IHP levels by 
Hansell et al (1981) and Angle et al. (1985). 
Similarly, there are few reports on the effect of oxygen 
partial pressure on hypoxanthine uptake and release. 
Salerno et al. (1986) have recently reported that oxygen can 
lower the rate of IHP synthesis in human erythrocytes. 
Henderson and Le Page (1959) and Hershko et al. (1967) 
reported that loss of adenine nucleotide purine from 
erythrocytes was greater under aerobic than anaerobic 
conditions. However, Schraufstatter and Born (1981) found 
no difference under their conditions at pH 7.4. 
Here, the uptake and release of hypoxanthine under conditions 
of varying inorganic phosphate concentrations, pH and p0 2 
have been studied. It has been shown that uptake and 
conversion of hypoxanthine to IHP is enhanced by increasing 
inorganic phosphate, and decreasing pH and p02 • It has also 
been shown that release of IHP as hypoxanthine is favoured at 
low inorganic phosphate concen~rations, high pH and high p0 2 • 
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2.2 MATERIALS AND METHODS 
2.2.1 Metabolism of oxypurines by erythrocytes 
Fresh heparinised human blood obtained by venipuncture was 
centrifuged at 4°C for 12 minutes at 1700 g and the plasma, 
buffy coat and top 1/Sth of red cells aspirated and discarded 
to remove nucleated species. The remaining cells were then 
washed twice with 3 volumes of ice-cold 0.9% saline. The 
washed erythrocytes were then incubated in medium consisting 
of HEPES (50 mM), glucose (10 mM), Na2HP04 (10 mM) and NaCl 
(75 mM) at a packed cell to medium ratio of 1:2 (v/v). pH 
was adjusted by the addition of 1 M HCl or 1 M NaOH. In 
some experiments the medium contained in addition 14c-
hypoxanthine (100 ~M, 1.2 Ci/mol) (Amersham, Buckinghamshire, 
England) or 32pi (5 mCi/mol) (Amersham, Buckinghamshire, 
England). To quantitate labelled purine species, an aliquot 
of suspension, typically 0.5 ml, was briefly centrifuged at 
10000 g through dibutylphthalate (Merck, Schuchardt, 
Germany), as described by Wohlhueter et ~· (1978) in a 1.5 
ml microfuge tube, and after aspiration, the supernatant 
medium deproteinized with an equal volume of 0.6 M perchloric 
acid. The dibutylphthalate was aspirated and the red cell· 
pellet resuspended in an equal volume of isotonic saline, 
followed by 2 volumes 0.6 M perchloric acid. After 
centrifugation an aliquot of the clear supernatant was mixed 
with scintillation fluid and counted by scintillation 
photometry using an open window setting. From the specific. 
activity, the uptake of purine or phosphate could be 
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expressed in ~M or mM respectively. In some cases aliquots 
were neutralized with 2.5 M K2co3 , and after centrifugation 
the supernatant (typically 50 ~1) was injected onto an anion 
exchange or reverse phase HPLC column (details of HPLC given 
below). Eluate fractions were counted and from the position 
of markers individual labelled purine species were identified 
and quantitated. In experiments where 32Pi was used, the 
individual labelled 32 P species were separated in a similar 
manner, using anion exchange HPLC. The Pi concentration of 
cells and medium was measured by the colorimetric method of 
Fiske and SubbaRow (1925). The pH of the red cell 
suspensions was determined to 2 decimal places using an ABL 
blood gas analyser (Radiometer, Copenhagen, Denmark). 
Incubation of red cells in whole blood was performed by 
addition of Na 2HP0 4 , glucose, and 
14c-hypoxanthine to freshly 
drawn heparinized blood to give a final concentration of 10 
mM, 10 mM and 100 ~M respectively without significant 
increase in volume. 
equilibration with 
before and after 
hypoxanthine uptake. 
pH was reduced to approximately 7 by 
20% co2 in oxygen. Samples were removed 
a 90 minute incubation to determine 
Following incubation, erythrocytes 
were isolated by centrifugation through dibutylphthalate and 
resuspended in autologous fresh plasma. A baseline sample 
was removed at this stage. The pH of the suspension was 
increased by equilibration with air to displace co 2 • 
Samples of varying pH were removed during this procedure and 
incubated for 1 hour to determine hypoxanthine release. The 
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concentration of Pi, total labelled purine, and in some cases 
individual purines was determined as described above for 
cells incubated in defined aqueous medium. Blood pH and p02 
was measured on an ABL blood gas analyser (Radiometer, 
Copenhagen, Denmark). Plasma lactate was measured on the 
perchloric acid extracts by monitoring the formation of NADH 
in the presence of lactate dehydrogenase (Bergmeyer, 1974). 
2.2.2 Cell-free preparations (dialysed haemolysate) 
Haemolysate was prepared according to Steyn and Harley 
(1984). Enzyme extracts were prepared from 10 ml of fresh, 
heparinised human blood. The plasma and buffy coat were 
removed after centrifugation at 
The red blood cells were washed 
1700 x g for 
twice with 2 
10 minutes. 
volumes of 
normal saline and were lysed by adding 4 volumes of distilled 
the stroma was removed by centrifugation. 
The haemolysate was 
changes of 5 litres 
mM dithiothreitol. 
dialysed for 16 h at 4°C against two 
of 50 mM Tris-HCl, pH 7.8, containing 1 
The dialysed lysate was frozen in 
aliquots of 500 ~1, and stored at -20°C for not longer than 4 
weeks, by which time Steyn and Harley (1984) demonstrated 
that there was a 10% loss of hypoxanthine-guanine 
phosphoribosyl transferase (HPRT) activity. The thawed 
lysates were used in the PRPP assay described below. 
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2.2.3 PRPP assay 
The PRPP content of erythrocytes was measured by slight 
modification of the method of Hershko et al. (1969), in which 
14 C-IMP formed in the presence of 14 C-hypoxanthine and 
hypoxanthine-guanine phosphoribosyltransferase (HPRT) 
reflects the PRPP originally present. Typically, 20 ~1 EDTA 
(10 mM) was added to 200 ~1 aliquots of packed red cells in 
1,5 ml microfuge tubes which were heated at 100°C for 1 
minute. The samples were chilled and mixed with 50 ~1 of a 
10% suspension of activated charcoal. The charcoal adsorbs 
endogenous nucleotides and together with precipitated protein 
was deposited by centrifugation at 10000 g. 30 ~1 of clear 
supernatant was incubated for 3 hours at 37°C with 20 ~1 of a 
combined reagent containing Tris HCl (0.1 M, pH 9.0), MgC1 2 
(30 mM), 14c-hypoxanthine (300 ~M, 5 Ci/mol) and 40% vjv of 
the dialysed haemolysate from normal erythrocytes as a source 
of HPRT. 15 ~1 aliquots of the incubation mixture were 
spotted in duplicate onto 2 em diameter discs marked with 
pencil on polyethyleneimine (PEl) phosphocellulose thin layer 
plates (Merck, Darmstadt, Germany) and washed exhaustively 
with distilled water to remove 14 C-hypoxanthine. The discs 
were then dried, cut out and placed in counting vials with 10 
ml Instagel (Packard) and counted in a Beckman LS-233 
scintillation counter to quantitate the 14 c-IMP bound. The 
assay was standardized using solutions of 0, 50, 100, 150 and 
200 ~M PRPP in place of sample. 
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2.2.4 PRPP synthetase assay 
A partially purified preparation of PRPP synthetase was 
prepared following the procedure of Hershko et ~· (1969) and 
Hennessy et ~. ( 1962). All steps were performed at 4°C. 
S ml of fresh washed packed cells were lysed in 15 ml cold 
EDTA (1 mM) and stirred for 10 minutes with 200 mg activated 
charcoal. After centrifugation at 3000 g, the supernatant 
was stirred for 20 minutes with 10 ml of a 10% suspension of 
DEAE-cellulose prepared according to Hennessy et ~· (1962). 
Following adsorption of the haemolysate the DEAE-cellulose 
was washed with 3 mM potassium phosphate, pH 7, in a Buchner 
funnel until the effluent was colourless. The enzyme was 
eluted by stirring the DEAE-cellulose for 20 minutes in 10 ml 
O.S M KCl containing 1 mM EDTA following which the matrix was 
deposited by centrifugatioan and the supernatant enzyme 
solution stabilized by the addition of '100 mg albumin, 
dialyzed for 4 hours against Tris HCl (10 mM, pH 7.4) and 
stored in aliquots at -20°C. The assay of PRPP synthetase 
was performed according to the two-step procedure of Hershko 
et al. (1969), but with slight modification. In the first 
step, synthesis of PRPP was allowed to proceed in a reaction 
mixture containing, in a final volume of 1.10 ml, the 
following ingredients: SO mM Tris-HCl (pH as specified), SmM 
MgS04, 2.5 mM reduced glutathione (GSH), 1 mM EDTA, Na2HP0 4 
(concentration and pH as specified), 0.1 mM ATP, 1 mM Ribose-
S-phosphate (R-S-P), 0~1 mM ATP, 1 mM phosphoenol pyruvate, 
10 ~1 pyruvate kinase (Boehringer) and 0.1 ml of the DEAE-
cellulose-treated enzyme preparation described above. The 
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reaction mixture was then incubated at 37°C. At 10 minute 
intervals, from 0 to 40 minutes, 200 ~1 aliquots were removed 
and the reaction terminated by immersing the tubes in boiling 
water for 1 minute. The tubes were then immediately chilled 
on ice, and 100 ~1 of a freshly mixed 10% activated charcoal 
solution added to adsorb ATP and other nucleotides-. The 
charcoal was deposited by centrifugation and aliquots of the 
clear supernatant were used in the second step of the assay 
in which the amount of PRPP formed was determined as 
described above. 
2.2.5 High Pressure Liquid Chromatography (HPLC) 
The separation of oxypurine metabolites was effected by HPLC 
(Spectra Physics Model 3500 B) of neutralized perchloric acid 
extracts of erythrocytes using both anion exchange and 
reverse phase columns. Anion exchange chromatography was 
performed on a Hichrom APS HVP-2511 column (Hichrom, Reading, 
England), with a linear buffer gradient developed over 10 
minutes from 5 mM KH 2 Po4 (BDH, Aristar grade) pH 2.50, to 500 
mM KH 2Po 4 plus 912 mM KCl, pH 3.8 at a flow rate of 1.2 
ml/min. Depending on the retention times of the metabolites 
being studied, thirty or sixty second fractions of the 
effluent were collected, mixed with scintillation fluid 
(HIONIC-FLUOR, United Technologies Packard, Downers Grove, 
Illinois, USA) and counted in a Beckman LS 233 liquid 
scintillation system. 
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Reverse phase chromatography was performed on a Hichrom S50 
DS-3571 column (Hichrom, Reading, England), using 5% methanol 
in 1 mM KH 2Po 4 (v/v) as an !socratic buffer at a flow rate of 
1.6 ml/min. Fractions were collected and counted as 
described above. In all cases the absorbance of the 
effluent was monitored at 260 nm. 
2.2.6 2,3-Bisphosphoglyceric Acid (2,3-DPG) assay 
2,3-DPG was quantitated 
Chemical Company, 
principle of the 
St Louis, 
test 
using a commercial kit (Sigma 
USA, catalog number 665). The 
is as follows: 2,3-DPG is 
enzymatically hydrolysed to 3-PGA and Pi. The enzyme which 
catalyses this reaction is present in purified preparations 
of phosphoglycerate mutase (PGM) and is termed 2,3-DPG 
phosphatase. 2-Phosphoglycolic acid is needed as an 
activator for this reaction (Rose, 1970; Rose and Liebowitz, 
1970b). It is not yet certain whether this reaction is 
caused by a contaminating enzyme in the PGM or is the result 
of a secondary function of PGM (Lowry et ~., 1964). The 
reaction is allowed to go to completion and the resulting Pi 
is. then colourimetrically determined by the method of Fiske 
and SubbaRow (1925). 
2.2.7 Effect of p02 on hypoxanthine uptake by erythrocytes 
Fresh heparinised human blood from a healthy volunteer was 
centrifuged for 10 minutes at 1700 g and the plasma, buffy 
coat and top 1/5th of red cells removed. The infranatant 
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cells were washed twice with 3 volumes of ice-cold saline and 
resuspended in 3 volumes buffer containing, in 
concentration, HEPES 50 mM; 1, 5 or 10 mM; 
final 
14c-
hypoxanthine 120 1-1M (5 Ci/mol); glucose 10 mM; and NaCl to 
provide a final osmolality of 290 mOsm/kg. pH was adjusted 
to 7.1 with NaOH. After equilibration with air at room 
temperature, 0.7 ml samples of the erythrocyte suspension 
were removed and introduced under dibutylphthalate in a 1.5 
ml microfuge tube which was then closed and kept at room 
temperature. The pH and p02 of an aliquot of the 
erythrocyte suspension was measured. Nitrogen gas was then 
bubbled through the remaining suspension at room temperature 
and at appropriate intervals 0.7 ml aliquots were removed and 
treated as described above until the p02 had dropped to 2.7 
kPa or below. All the microfuge tubes were then incubated 
at 37°C for 90 min with intermittent inversion to ·keep the 
erythrocytes suspended. After incubation the erythrocytes 
were separated from the medium by centrifugation; the 
dibutylphthalate settled between the heavier red cells and 
less dense medium. 50 1-11 aliquots of the pelleted 
erythrocytes were then lysed with 100 and 
deproteinized with 150 1-11 0.6 M perchloric acid. After 
centrifugation and the supernatant fluid was neutralised with 
2.5 M K2co3 the total erythrocyte content of labelled 
oxypurine was 
supernatant. 
determined by counting an aliquot of 
The nature and quantity of individual 
hypoxanthine metabolites in the cells was determined using 
both reverse phase and anion exchange chromatography; 
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appropriately timed aliquots of the effluent were collected 
and counted. 
All estimations were performed in duplicate. The difference 
between duplicates expressed as a percentage of the mean was 
found to be less than S percent in most cases and less than 
10 percent in all cases. 
2.2.9 Preparation of activated charcoal 
200 g of commercial grade activated charcoal (Sigma Chemical 
Co., St Louis, Missouri, catalog no. C-4396) were suspended 
in S to 10 volumes of 1 M HCl and boiled for 15 to 20 
minutes. After cooling and allowing the charcoal to settle 
the supernatant fluid was decanted and discarded. The 
charcoal was then washed several times with 1 M KCl until the 
pH of the supernatant approached 7.0 (the supernatant was 
decanted after allowing the charcoal to settle each time). 
This required many washes. The charcoal was washed 7 to 10 
times with high purity H2o and then dried in a beaker covered 
with cheesecloth in an oven at less than 40°C. 
2.2.9 Preparation of DEAE cellulose 
DEAE cellulose was prepared according to Hennessey et al. 
(1962). 40 g of commercial DEAE cellulose was suspended in 
(pH 9.1), stirred mechanically for 1 
hour and filtered with suction. This step was repeated 
several times until the filtrate was colourless. The 
adsorbent was washed further with distilled water until the 
7 1 
pH of the filtrate was approximately 7.0. An aqueous 
suspension (8 g per 100 ml) of the adsorbent was adjusted to 
pH 7.0 and stored at room temperature. 
2.3 RESULTS 
2.3.1 I Effect of pH on oxypurine metabolism 
Washed human erythrocytes were incubated at 37°C for 2 hours 
in HEPES buffered medium containing 10 mM Pi and 100 ~M 14c 
hypoxanthine at varying pH. In a parallel experiment, cells 
pre-incubated at the lowest pH (7.1) for 2 hours were 
alkalinized by the progressive addition of NaOH to give a 
second set of samples of varying pH which were incubated for 
a further period of 2 hours at 37°C. Cells from both the 
first and second incubations were separated from medium by 
centrifugation through dibutylphthalate and the distribution 
of labelled purine species determined by anion exchange and 
reverse phase chromatography~ 
The results of the first 2 hour incubation are given in Fig. 
2.1A and show that IMP is synthesized in progressively 
greater amounts with decreasing pH. Minimal quantities are 
present after 2 hours above pH 7.5. When incubation of 
cells at pH 7.1 is continued at the same pH value (Fig. 2.18) 
for a further 2 hours the conversion of hypoxanthine to 
intracellular IMP becomes essentially complete. However, 
subsequent alkalinization of cells pre-incubated for an 
initial 2 hours at pH 7.1 resulted in a reversal of this 
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Fig. 2.1. Variation with pH in uptake and metabolism of 
hypoxanthine by erythrocytes. 
(A), incubation for 2 hat 37°C in 10 mM Pi and 100 ~M 14c-
hypoxanthine. (B), Pre-incubation for 2 h in 10 mM Pi and 
100 ~M 14C-hypoxanthine, pH 7.15, followed by alkalinization 
and incubation for a further 2 h. te.---ee, intracellular IMP; 
•.----::&.6 , intracellular hypoxanthine; ••1----1••, intracellular 
inosine; ~ , medium hypoxanthine. Units on the 
abscissa are in ~mol/1 packed erythrocytes or ~mol/1 medium. 
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process, with depletion of intracellular IMP and 
reappearance of hypoxanthine. At pH values above 7.6 
detectable quantities of inosine accumulated. Intracellular 
hypoxanthine concentrations were generally similar to those 
in the medium, irrespective of pH, consistent with the known 
rapid equilibration of hypoxanthine across red cell membranes 
(Lassen, 1967). 
2.3.2 Effect of inorganic phosphate on hypoxanthine 
metabolism 
The effect of varying Pi concentrations on IMP formation in 
intact erythrocytes at a number of different pH values is 
shown in Figs. 2.2 and 2.3, and demonstrates the Pi 
dependence of IMP accumulation. No IMP accumulates at any 
pH in the absence of Pi in the medium. In the presence of 
external Pi, IMP accumulation and corresponding medium 
hypoxanthine depletion is dependent on pH, such that at a 
given Pi concentration, decreasing pH results in a 
progressively greater IMP accumulation. 
2.3.3 Effect of pH on PRPP formation 
To investigate the mechanism whereby low pH enhances IMP 
synthesis, erythrocytes were incubated for varying times in 
medium similar to that used for the experiment illustrated in 
Fig. 2.1A but containing no hypoxanthine. The PRPP content 
of the 
of pH 
erythrocytes at 
in Fig. 2.4, 
varying times is shown as a function 
and demonstrates that detectabl~ 
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Fig. 2.2. Variation with extracellular Pi in uptake and 
conversion of hypoxanthine to IMP by erythrocytes. 
(A), accumulation of IMP in erythrocytes and (B) depletion of 
hypoxanthine in medium after 1 h incubation at 37°C in 60 ~M 
14c-hypoxanthine (1.2 Ci/mol). 
••--~••, pH 7.11; Q----0 , pH 7 • 2 6; ... , .;...__ • ..,. , pH 7 • 4 8; 
1::.., pH 7.82. rbc's, packed erythrocytes. 
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Fig. 2.3. Reverse phase HPLC of erythrocyte oxypurines. The 
erythrocytes were incubated with 14c-hypoxanthine as 
described in Fig. 2.2, in media of varying pH and Pi 
concentration. The minimum number of fractions required for 
resolution of the three species were collected. Arrows show 
the elution positions of unlabelled markers of inosine 5'-
monophosphate (IMP), inosine (In) and hypoxanthine (Hx). 
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accumulation of PRPP occurs only at acid pH, proceeding at a 
maximum rate of about 100 ~moles per litre erythrocytes per 
hour at pH 7.0. The initial content of PRPP is less than 5 
~moles/litre, reflecting the situation in circulatirig 
erythrocytes, and remains unchanged at pH values above 7.6. 
2.3.4 Effect of pH and Pi on PRPP synthetase activity 
The mechanism for the pH dependence of PRPP synthesis seen 
above wa~ investigated by determining the activity of PRPP 
synthetase in a partially purified haemolysate as a function 
of pH and Pi concentration. The data are given in Table 2.1 
and show that whilst PRPP synthetase is highly dependent on 
Pi concentration for activity, it is relatively unaffected by 
pH, showing a broad optimum around pH 7.5. This agrees with 
the findings of Fox and Kelley (1971a). 
2.3.5 Effect of pH on phosphate uptake and metabolism 
Since the Pi concentration has such a marked effect on PRPP 
synthesis, both in intact cells and cell-free haemolysates 
(Fox and Kelley, 1971a and b), the ingress of phosphate and 
the intracellular Pi concentration were measured in cells 
incubated in media containing 10 mM 32 P labelled Pi at a 
number of different pH values. After incubation for 1 hour 
the cells and medium were harvested and the intracellular Pi 
concentration measured calorimetrically. The total uptake 
of phosphate was determined by measurement of 32 P content of 
both cells and medium (Fig. 2.5A). In a parallel experiment 
' 
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TABLE 2.1 
Effect of pH and inorganic phosphate on PRPP synthetase 
activity in dialysed erythrocyte haemolysate 
pH Pi PRPP synthetase activity 
(mM) (~mol/hr/ml) 
6.76 5 0.63 ± 0.05* 
7.17 5 0.98 ± 0.14 
7.73 5 1.03 ± 0.03 
7.85 5 0.94 ± 0.03 
8.35 5 0.82 ± 0.03 
7.85 0 0.06 ± 0.01 
7.85 2 0.64 ± 0.04 
7.83 5 0.63 ± 0.03 
7.85 10 0.73 ± 0.02 
7.85 20 0.87 ± 0.06 
* The values are means ± 1 SD. The determinations were 
carried out in quadruplicate. Pi, inorganic phosphate; 
PRPP, 5-phosphoribosyl-1-pyrophosphate. 
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influx of 
extracellular Pi and the free intracellular Pi concentratipn 
in erythrocytes. 
(A), incubation of erythrocytes for 1 h at 37°C with 10 mM 
32p labelled Pi. (B) Erythrocytes pre-incubated for 1 h at 
37°C in 10 mM [32P]Pi at pH 6.9 as described in (A), then 
divided into aliguots and the pH adjusted to values between 
6.9 and 7.9. These were incubated for a further hour at 
••~--•• , free intracellular Pi (mmol/1 p'acked 
erythrocytes); ••~--•• , total erythrocyte 32 P (amount of 32pi 
accumulated from the medium into both free and esterified 32p 
phosphate) (mmol/1 packed erythrocytes); ~, medium 32pi 
( mM). 
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cells incubated for one hour at pH 6.8 under the conditions 
described above were subsequently divided into aliguots and 
the pH adjusted to provide a second set of suspensions 
covering a pH range of 6.8 to 7.9. These were incubated for 
a further hour at 37°C, then processed in the same manner as 
the first set (Fig. 2.58). The results showed that 
acidification of cells suspended in a phosphate-containing 
medium results in a steep, non-linear increase in the 
intracellular Pi concentration. The influx of phosphate, 
measured by the intracellular accumulation of 3 2p, also 
increass with decreasing pH but in a more linear manner and 
to a lesser extent, as shown by the shallower slope. This 
is reflected by a corresponding decrease in 32p concentration 
in the medium. These results indicate that at higher pH -
values the entry of Pi into erythrocytes is slower and that 
much of the phosphate that does enter is no longer measurable 
as free Pi. At lower pH values phosphate entry is faster 
and is measurable as free Pi; in fact, the levels of 
intracellular Pi exceed those resulting from phosphate influx 
alone. In the second part of the experiment (Fig. 2.58) it 
can be seen that alkalinization of cells preloaded with 
phosphate at acid pH results in a fall, progressive with 
increasing pH, of intracellular free Pi concentration, with 
little change in total 3 2 p content. This is confirmed by 
anion exchange HPLC of extracts from cells incubated at the 
extremes of pH (Fig. 2.6). A redistribution occurs in the 
relative amounts of 32 P labelled species with increasing pH; 
32pi falls, with a concomitant increase in more anionic 3 2p 
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Fig. 2.6. Anion exchange HPLC of cell extracts corresponding 
to the most acid (pH 6.84) and alkaline (pH 7.95) incubation 
conditions described in Fig. 2.58. 
The distribution of 32 P labelled compounds is shown, with the 
elution position of Pi marked. The two 32 P containing peaks 
eluting after Pi were not identified, but their position 
suggests they represent highly anionic organic phosphates 
such as 2,3-DPG. 
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labelled compounds, the bulk of which is probably 2,3-DPG 
(Chiba and Sasaki, 1978). In an experiment where similarly 
incubated cells were transferred to a medium containing no 
phosphate for the second incubation step, efflux of inorganic 
phosphate from the cells occurred readily and was more 
pronounced at low pH values (data not shown). 
2.3.6 Effect of pH on adenine nucleotide levels 
Washed erythrocytes were incubated for 2 hours at 37°C in 
HEPES buffered medium containing 10 mM glucose and 10 mM Pi 
at varying pH. The neutralized perchloric acid extracts of 
the cells were chromatographed on anion exchange HPLC, and 
ADP and ATP levels measured relative to that of authentic 
standards of known concentration. The results are given in 
Table 2.2 and show that with increasing pH, there is an 
increase in the ADP, a fall in ATP and increased lactate 
accumulation. 
2.3.7 Effect of pH on oxypurine metabolism in whole blood 
To determine whether the accumulation of IMP and free Pi in 
erythrocytes showed the same pH dependence when suspended in 
plasma as in defined aqueous medium, whole blood equilibrated 
with co 2 to achieve a pH of 7.0 was incubated for 90 minutes 
at 37°C in the presence of 10 mM Pi and 100 ~M 14 c 
hypoxanthine. HPLC analysis of cell extracts prepared from 
aliquots removed after 5 minutes (Fig. 2.7a) and 90 minutes 
(Fig. 2.7b) showed progressive accumulation of IMP and 
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TABLE 2.2 
Effect of pH on adenine nucleotide levels and lactate 
production 
Erythrocytes were incubated at 37°C for 2 hours in 10 mm Pi 
at the pH values indicated. ADP and ATP levels were 
determined by anion exchange HPLC of cell extracts and 
expressed as ~mol per litre of packed erythrocytes. L-
lactate in the medium was measured by the enzymatic method 
described. 
pH RBC[ADP] RBC[ATP] Medium lactate 
(~moles/1) (~mo1es/1) mM 
7.12 78 893 1.87 
7.40 147 837 3.14 
7.71 202 663 3.60 
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Fig. 2.7. Anion exchange HPLC of erythrocyte oxypurines. 
Whole blood incubated with 10 mM Pi and 100 ~M 14c-
hypoxanthine at 37°C. pH adjusted to 7.0 by equilibration 
with 20% co2 in oxygen. HPLC analysis of intracellular 
purines was performed on aliquots removed after 5 minutes 
(2.7a) and 90 minutes (2.7b). The cells were centrifuged 
and resuspended in fresh autologous plasma containing no 
added hypoxanthine or Pi. Aliquots of cells removed before 
(2.7c) and after (2.7d) a further 90 minute incubation at pH 
7.0. A portion of freshly resuspended cells was 
equilibrated with air to increase the pH to 7.8, then 
incubated in parallel for 90 minutes (2.7e). The plasma from 
this alkaline suspension was also analysed (2.7f). 
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decrease in hypoxanthine. Following incubation, cells were 
'resuspended in fresh plasma equilibrated with co2 to maintain 
the pH at 7.0. Initially there was a slight decrease in 
cellular hypoxanthine (due to efflux into the fresh plasma) 
but no significant change in IMP levels (Fig. 2.7c). The 
resuspended erythrocytes were equilibrated with air for 
varying times to remove C02 and thus provide samples covering 
a pH range from 7.03 to 7.77. These suspensions were 
incubated for a further hour. Analysis of the plasma showed 
little release of radioactivity below pH 7.3 with a sharp 
increase above this pH (Table 2.3. HPLC analysis of plasma 
radioactivity from the· most alkaline aliquot (i.e. the one 
from which the most counts were released) showed that label 
was confined to hypoxanthine (Fig. 2.7f). Analysis of the 
cells incubated at pH 7.03 and pH 7.77 revealed that at low 
pH remaining hypoxanthine was quantitatively converted to IMP 
(Fig. 2.7d), whereas at high pH most of the IMP was degraded 
to hypoxanthine (Fig. 2.7e) which then diffused into the 
plasma (Fig. 2.7f). Table 2.3 also shows that there is a 
decline in intracellular Pi with increasing pH. This is not 
accompanied by a corresponding increase in plasma Pi, 
indicating that the fall in red cell Pi was not due to 
efflux, but rather due to intracellular consumption. The 
rate of lactate production increased progressively with .a 
rise in pH, reflecting a 2-fold enhancement of glycolysis 
over the observed pH range. 
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TABLE 2.3 
pH effects on red cells and plasma in whole blood prelabelled 
with phosphate and hypoxanthine 
Whole blood at pH 7.0 was incubated for 90 minutes at 37°C in 
the presence of 10 mM inorganic phosphate and 100 ~M labelled 
hypoxanthine. The erythrocytes were centrifuged, 
resuspended in fresh plasma, equilibrated with air for 
various times to give the range of pH values given in the 
table and then incubated for 60 min at 37°C. Measurements 
of purine and phosphate are expressed per litre of packed 
erythrocytes. 
------------------------------------------------------------
pH RBC purine Plasma Hx RBC Pi Plasma Pi Plasma 
(~moles/1) (~M) (mmoles/1) (mM) lactate 
(mM) 
7.03 131 1.6 5.48 3.86 2.19 
127 1.6 5.67 3.94 2.40 
7.20 130 1.9 4.94 3.51 2.49 
127 1.8 4.99 3.64 2.56 
7.29 129 2.7 4.54 3.50 2.54 
132 2.6 4.54 3.51 2.09 
7.47 106 22.3 3.06 3.33 3.44 
104 23.0 3.00 3.38 3.50 
7.72 77 40.9 1.92 3.21 3.82 
79 40.8 1.66 3.22 3.96 
7.77 71 47.1 1.53 3.42 4.40 
72 47.6 1. 70 3.50 3.91 
------------------------------------------------------------
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2.3.8 Effect of p0 2 on oxypurine metabolism 
To determine whether p0 2 affects hypoxanthine uptake, 
erythrocytes were incubated with 14 c hypoxanthine at pH 7.1 
under conditions of varying p0 2 in the presence of three 
different Pi concentrations (Fig. 
increased at p02 values less 
concentrations studied. 
2.4 DISCUSSION 
2.8). 
than 7 
IMP synthesis 
kPa at all 
was 
Pi 
The effects of pH in the range 7.0 to 7.8 on erythrocyte 
oxypurine metabolism shown in this study may be related to 
the pH dependent changes in a number of intracellular 
compounds. 
A fall in pH results in a rise in intracellular Pi. This 
may occur by two mechanisms. The first is by enhanced 
transport of Pi from the medium via the band 3 membrane 
protein which transports both divalent and monovalent anions 
(Passow, 1986). Transport of divalent anions, includirig Pi, 
by band 3 is increased with decreasing pH, with the maximum 
rate at pH 6.4 (Passow, 1969 and 1986; Gunn, 1973 and 1979; 
Schnell et ~., 1981), whereas monovalent anion transport is 
maximal at pH ~-0 (Funder and Wieth, 1976; Gunn, 1973). 
The pH dependence of phosphate transport into the red cell 
shown here is consistent with these characteristics of the 
band 3 protein. The second mechanism influencing red cell 
intracellular Pi concentration is the effect the prevailing 
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Fig. 2.8. Variation with p0~2 ____ i~n ____ ~t~h~e~--~m~e~t~a~b~o~l~i~s~m~--o~f 
hypoxanthine to IMP in erythrocytes. 
Erythrocytes incubated for 90 minutes at 37°C with 120 ~M 
14c-hypoxanthine at pH 7.1 in the presence of varying 
concentrations of Pi: ( ••~-•• , 1 mM Pi; o----<> , S mM Pi; 
e e, 10 mM Pi); rbc's, packed erythrocytes. 
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pH has on the distribution of phosphate between 
phosphorylated glycolytic intermediates (predominantly 2,3-
DPG) and Pi. At alkaline pH values phosphate is sequestered 
into these organic phosphate esters (mainly 2,3-DPG): this 
\ 
follows the increased activities of the rate-limiting 
glycolytic enzymes hexokinase and phosphofructokinase under 
alkaline conditions (Schraufstatter and Born, 1981), and the 
decreased activity of 2,3-DPG phosphatase at alkaline pH 
(Duhm and Gerlach, 1974). A fall in pH results in a 
decrease in 2,3-DPG (Duhm and Gerlach, 1974; Chiba and 
Sasaki, 1978) and ADP, with a concomitant increase in 
intracellular Pi and ATP, and a fall in glycolytic flux 
(Minakami and Yoshikawa, 1966a and b; Newsholme and Leech, 
1983), as measured by the accumulation of lactate shown in 
Table 2.2. These changes may be explained by the nett 
conversion of 2,3-DPG to lactate. Since the production of 
lactate from 2,3-DPG yields twice as much ATP (2 mol/mol) as 
production from glucose (1 mol/mol), overall glycolytic flux 
falls and there is an increase in the ATP/ADP ratio (Bontemps 
et al., 1986). Increase in pH reverses all these changes. 
The rise in erythroc~te ATP levels and the drop in ADP levels 
at acid pH values, and the reverse at alkaline pH values were 
confirmed and are shown in Table 2.1. 
Levels of total erythrocyte 2,3-DPG fall with a decrease in 
pH (Chiba and Sasaki, 1978). However, much more rapid changes 
in the concentration of free 2,3-DPG are caused by the 
binding of this compound to haemoglobin (Benesch and Benesch, 
1974). 2,3-DPG binds preferentially to deoxyhaemoglobin, 
and a 10-fold lower concentration of 2,3-DPG has been 
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calculated by Bunn, Ransil and Chao (1971) to exist in fully 
deoxygenated as compared to fully oxygenated erythrocytes. 
By decreasing the affinity of haemoglobin for oxygen (the 
Bohr effect), a fall in pH will therefore enhance the binding 
of 2,3-DPG to haemoglobin and also lower free 2,3-DPG levels. 
It has been calculated that free intracellular magnesium ion 
(Mg2+) concentration rises from 0.6 to 1.9 mM as fully 
oxygenated blood becomes deoxygenated (Bunn et al., 1971). 
This is a result of the competition between deoxyhaemoglobin 
and Mg2+ for the binding of organic phosphates, mainly 2,3-
DPG and ATP. 
The activity of three principal enzymes of purine metabolism 
are regulated by the compounds discussed above. These are 
PRPP synthetase, purine 5'-nucleotidase, and AMP deaminase. 
Purified PRPP synthetase shows a broad pH optimum between 7.2 
and 7.4 (in contrast to PRPP synthesis in intact cells) and 
an absolute requirement for Pi (Fox and Kelley, 1971a and b). 
The results presented here confirm these findings. 
required for activation of PRPP synthetase (Fox and Kelley, 
1971a) although the low Km for activation (0.2 mM) implies 
that the variation in intracellular free Mg2 + concentration 
described above will have little regulatory influence. In 
contrast to Pi and Mg 2 +, .ADP and 2,3-DPG are allosteric 
inhibitors of PRPP synthetase activity (Hershko et al., 1969; 
Fox and Kelley, 1971a,b and 1972). The purine 5'-nu~leotidase 
of red cells is a cytosolic enzyme only recently described 
and characterised by Bontemps, van den Berghe and Hers 
(1988), who showed that the activity of this enzyme is 
9 1 
inhibited by Pi and activated by 2,3-DPG, effects opposite to 
those on PRPP synthetase. AMP de~minase has been shown to be 
allosterically inhibited by 2,3-DPG (Askari and Rao, 1968; 
Lian and Harkness, 1974); in the presence of 1-mM ATP and 100 
mM KCl Liam and Harkness demonstrated the Ki value to be 
between 4 and 11 mM. Work by Bontemps et al. (1986) has shown 
( 
that the initial catabolism of human erythrocyte AMP proceeds 
exclusively by way of AMP deaminase under physiological 
conditions and upon alkalinisation, and partially by this 
enzyme in glucose deprivation. 
The two other enzymes involved in hypoxanthine and IMP 
metabolism in the erythrocyte ~re hypoxanthine phosphoribosyl 
.transferase (HPRT) and purine nucleoside phosphorylase (PNP). 
Since both IMP and PRPP accumulation show a similar 
dependence on pH, it can be concluded that IMP synthesis in 
the presence of hypoxanthine is determined by PRPP 
availability, and that HPRT activity is not rate limiting. 
The rapid conversion of IMP to hypoxanthine at alkaline pH 
demonstrates that PNP is not usually rate limiting, except at 
high pH in the absence of external phosphate. Under these 
conditions, intracellular Pi concentration is at a minimum, 
and inosine becomes detectable, since Pi is required as co-
substrate for PNP (Kalckar, 1947; Kim, 1968; Lewis and 
Lowy, 1979). An alternative mechanism for the accumulation 
of inosine from hypoxanthine is by reversal of the more usual 
phosphorolysis (catalysed by purine nucleoside phosphory-
lase). This mechanism seems more likely since, when adenine 
was added (to deplete PRPP and thus prevent IMP formation 
catalysed by HPRT), inosine accumulated to the same degree 
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(P. Berman, unpublished observation). This-Pi dependence of 
PNP would be consistent with the reduction in plasma inosine 
seen in patients with elevated plasma Pi due to renal failure 
(Mansell et ~., 1981). 
A model for the regulation of oxypurine metabolism in the red 
cell is illustrated in Fig. 2.9 and proposes the following: 
Hypoxanthine, IMP, and inosine are components of an oxypurine 
cycle in erythrocytes. Under conditions of low pH and high 
extracellular Pi, intracellular Pi concentrations rise and 
levels of ADP and 2,3-DPG fall, the latter effect augmented 
at low p0 2 • The consequent stimulation of PRPP synthesis 
favours the conversion of hypoxanthine to IMP, and the latter 
accumulates due to inhibition of purine 5'-nucleotida~e by 
Pi. Enhanced synthesis of PRPP explains the increased levels 
of IMP and ATP (via salvage of adenine) found in erythrocytes 
of patients with chronic renal failure, where blood pH is 
invariably decreased and plasma Pi concentration incr~ased 
(Mansell et al., 1981). On returning to conditions of 
neutral or alkaline pH, low extracellular Pi, and high p02 , 
intracellular Pi levels fall (due to efflux and inclusion 
into glycolytic intermediates) and 2,3-DPG and ADP levels 
rise. These conditions result in a concerted activation of 
purine 5'-nucleotidase and inhibition of PRPP synthetase, 
with nett conversion of IMP to hypoxanthine. Efflux of the 
accumulating hypoxanthine is facilitated by rapid 
equilibration across the red cell membrane (Lassen, 1967; 
Harz et ~., 1979; Muller and Falkner, 1976). 
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A 
Pi 
Hx 
B 
Pi 
HbDPG """02 
X-P ~Hb02 
/ DPG 
Hx 
Fig. 2.9. Model depicting the factors regulating IMP and 
hypoxanthine metabolism in (A) conditions of acid pH, low p0 2 
and high external Pi concentration, and (B) conditions of 
..:.;n~e::..:u::.t.:::.:.r.!:a~l~~o~r'--~a...:!:l~k~a~l.:i.!;n!..::e:..._--t:P:.!.;H!.J,~....!.!h!...:!i:.;g~h!.!____..~;P~O 2 and 1 ow extern a 1 Pi 
concentration. 
DPG, 2,3-bisphosphoglycerate; Hb, hemoglobin; Hx, 
hypoxanthine; Ina, inosine; IMP, inosine 5'-monophosphate; 
Pi, inorganic phosphate; PRPP, 5-phosphoribosyl-1-
pyrophosphate; R5P, ribose-5-phosphate; X-P, phosphorylated 
glycolytic intermediates, including 2,3-DPG. 
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Low pH, high Pi, and low p02 , which favour the uptake of. 
hypoxanthine by 
tissue (Garlick 
erythrocytes, are found in poorly oxygenated 
1979; Radda et &·, 1983) and 
suggest that the erythrocyte oxypurine cycle might provide a 
mechanism for the transfer of hypoxanthine from less 
oxygenated to more oxygenated tissue ~vivo. Although the 
Pi levels studied are somewhat in excess of physiological, a 
several fold increase in Pi concentration has been shown in 
intact ischaemic tissue by 31 P NMR (Radda, 1983; Radda et 
at., 1983; Ross et at., 1981). The cycle might also play a 
role in a more pathophysiological context, since in frankly 
ischaemic tissue hypoxanthine is known to accumulate (Osswald 
1977; Harkness et &·, 1984; Saugstad, 1975) and 
has been implicated in the causation of reperfusion injury 
(McCord, 1985). 
95 
CHAPTER 3 
TRANSPORT OF OROTATE INTO THE HUMAN ERYTHROCYTE AND ITS 
METABOLISM THEREIN 
3.1 INTRODUCTION 
Understanding of orotate physiology is generally limited to 
its role as an intermediate in the de ngyQ pathway of 
pyrimidine biosynthesis. Most human cell cultures take up 
orotate poorly, if at all (Plagemann, 1971; Imura et al., 
1972) and in the whole animal the liver and kidney are the 
predominant tissues to utilise orotate as a precursor of 
pyrimidine nucleotides with orotate being transported in 
these tissues by the organic acid transport system 
(Handschumacher et ~., 1979). The presence of orotic 
aciduria in a number of pathophysiological states such as 
hereditary orotic aciduria (Huguley et ~., 1959; Smith et 
~., 1961), allopurinol administration (Kelley and Beardmore, 
1970), and especially in hyperammonaemia (Levin et ~., 
1969), demonstrate that orotate is capable of a significant 
flux from the liver into the plasma and ultimately, in the 
above conditions, into the urine. 
During studies on erythrocyte pyrimidine metabolism in a 
patient with haemolytic anaemia caused by erythrocyte 
pyrimidine 5'-nucleotidase deficiency, it was found that 
in transporting and erythrocytes showed high activity 
metabolising orotate to pyrimidine nucleotides (Harley, 1978; 
Harley et ~., 1978), and it was proposed that this was a 
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major pathway contributing to the erythrocyte pyrimidine 
nucleotide accumulation 
(Harley and Berman, 1984). 
characteristic of this disorder 
The erythrocyte has long been accepted as playing a role in 
transport of purines between tissues in the whole organism. 
The presence of active pyrimidine metabolism in the 
erythrocyte together with the demonstrable potential for the 
liver to export excess orotate into the blood compartment 
suggests that the erythrocyte might also play a role in 
distributing pyrimidines synthesised in the liver to 
peripheral tissues. 
The demonstration by Berman and Harley (1984) that the 
presence of erythrocytes enabled cultured fibroblasts or 
lymphoblasts to utilise orotate for nucleic acid synthesis 
lends support to this hypothesis. 
Here the mechanism of orotate transport in the erythrocyte 
and physiological aspects affecting the metabolism of the 
transported orotate are investigated in the light of the 
findings reported in the previous chapter about the way in 
which pH and phosphate concentration control erythrocyte 
hypoxanthine and IMP metabolism. The results indicate that 
orotate is transported across the erythrocyte membrane by the 
band 3 anion transporter, 
influenced in 
concentration. 
a complex 
and its metabolic role is 
way by pH and phosphate 
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3.2 MATERIALS AND METHODS 
3.2.1 Separation and extraction of erythrocytes 
Fresh human venous blood from healthy volunteers was taken 
into lithium heparinised vacuum tubes, and centrifuged at 4°C 
for 12 minutes at 1700 x g. The plasma, buffy coat and top 
1/5th of erythrocytes were aspirated and discarded. The 
remaining cells were then washed three times, with 3 volumes 
of ice-cold 0.9% saline. 
Erythrocytes were separated from incubation medium by the 
technique of Wohlhueter et ~· (1978). Typically, 400 ~1 of 
dibutylphthalate (Merck, Schuchardt, Germany) was added to 1 
ml erythrocyte suspension in a 1.5 ml microfuge tube and 
,centrifuged for approximately 5 seconds at 10000 x g. The 
pelleted erythrocytes are then separated from the supernatant 
medium by a discrete layer of the dibutylphthalate. A small 
amount of medium is carried down through the dibutylphthalate 
in the unstirred water layer that surrounds erythrocytes. 
After the supernatant had been aspirated, contaminating 
droplets of medium on the sides of the tubes were removed by 
gently layering distilled water on top of the 
dibutylphthalate. The distilled water and most of the 
dibutylphthalate were then aspirated, care being taken not to 
remove any of the pelleted erythrocytes. The small amount 
of dibutylphthalate left covering the erythrocyte pellet was 
deposited with the precipitate after the addition of the 
perchloric acid described below. The packed erythrocytes 
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were then resuspended in an equal volume of normal saline. 
The erythrocytes were then extracted with 2 volumes of ice-
cold 0.6 M perchloric acid, allowed to stand for 5 min in ice 
and after centrifugation 
neutralised with 2.5 M K2co 3 • 
the clear supernatant was 
After further centrifugation 
the supernatant was used for analysis. 
3.2.2 Trans-membrane transport of orotate (dibutylphthalate 
method) 
To deterine the rate of transport of orotate into human 
erythrocytes, each time course was commenced by adding an 
aliquot (usually 700 ~1) of fresh, washed, packed human 
erythrocytes (prewarmed medium consisting of HEPES, orotate, 
NaCl (concentrations, and pH's adjusted with NaOH, as 
specified) and tracer amounts of 14c-orotate (Amersham, UK.). 
In some experiments sucrose was substituted for NaCl. 
Immediately after addition of the erythrocytes to the medium 
the incubate was mixed thoroughly and maintained at the 
incubation temperature in a water bath with continuous gentle 
agitation. Just prior to the specified times duplicate 250 
~1 aliquots were removed from the incubate and transferred to 
microfuge tubes containing 400 ~1 dibutylphthalate prewarmed 
to the incubation temperature. At the specified times the 
erythrocytes were separated from the orotate containing 
medium by 
which they 
the medium 
switching on the microfuge (Eppindorf, Germany) in 
had been placed. This separates the cells from 
in less than 2 seconds (Wohlhueter et ~., 1978). 
The pelleted erythrocytes were extracted as described above 
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and aliquots of the clear supernatant were counted by 
scintillation photometry in a Beckman LS-233 scintillation 
counter to determine the amount of orotate that had entered 
the erythrocytes. The sample of the supernatant from each 
of the final time points was neutralised and subjected to 
anion exchange HPLC. 
3.2.3 Transmembrane transport of orotate (HgC1 2 method) 
In some orotate uptake experiments a method adapted from that 
used by Lieu et ~· (1971) was used. Incubations were 
carried out in HEPES-buffered saline (concentrations and pH 
specified). Time courses were started by adding 1.0 ml of 
packed, washed erythrocytes, pre-equilibrated at 37°C, to 3.0 
ml of the specified 14c-orotate containing buffer also pre-
equilibrated at 37°C, mixing, and incubating at 37°C. At 
specified times 500 ~1 aliquots were removed and added to 
approximately 8 ml ice-cold HgC1 2 -stopping solution [HgC1 2 
(2.0 mH); Kl (1.25 mH) and NaCl (340 mH)] which prevents the 
transport of pyrimidine nucleotides across erythrocyte mem-
branes (Lieu et al., 1971). Mercury, the active ingredient, 
combines readily with sulphydril groups in proteins, thus 
interfering with their function. The samples were then 
immediately centrifuged at 650 x g at 4°C for 60 seconds; 
the centrifuge took a further 90 seconds to come to 
standstill. The supernatant 
erythrocytes were washed with 
was decanted and the pelleted 
a further 8 ml of ice-cold 
HgC1 2 solution and repeating the centrifugation. Then 0.5 ~1 
0.9% saline was added to resuspend the cells prior to 
precipitation of proteins by the addition of an equal volume 
of 15% TCA. After centrifugation the cl~ar supernatant was 
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added to 10 ml scintillation fluid (Instagel, United 
Technologies Packard) and counted in a Beckman LS-233 Liquid 
Scintillation System. 
In some experiments specific inhibitors of anion transport 
known to act at different sites on the band 3 protein 
1986) were (Cabantchik et ll•, 1978; Falke and Chan, 
employed: 4,4'-diisothiocyanostilbene-2,2'-disulfonate(DIDS) 
(Sigma, cat No. D-3514) (Grinstein et ~., 1978; Shami et 
1978) and alpha-cyano-4-hydroxycinnamate (CHCA) 
(Halestrup, 1976). 
3.2.4 Metabolism of orotate by erythrocytes 
Washed erythrocytes at a 
(v/v) were incubated in 
at 37°C. 
mM), 14c 
The medium 
orotate (10 
packed cell to medium ratio of 1:5 
duplicate in 1.5 ml microfuge tubes 
contained HEPES (50 mM), glucose (10 
~molar, 61 Ci/mol) (Amersham, 
Buckinghamshire, England), NaH2 Po4 (concentrations 
specified), with pH adjusted to specified values with NaOH, 
and adjusted to isotonicity with NaCl. After 4 hours 
incubation with constant gentle agitation the cells were 
separated from the medium by centrifugation thro.,ugh 
dibutylphthalate. 200 ~1 of the clear supernatant was 
removed, added to an equal volume of ice-cold 0.6 M PCA, 
vortexed, allowed to stand for 5 minutes and then 
centrifuged. The clear supernatant was neutralised with 2.5 
and analysed as specified. The pelleted 
1 0 1 
erythrocytes were extracted as described above. Pi 
determination was by the method of Fiske and SubbaRow (1925). 
3.2.5 High Pressure Liquid Chromatography (HPLC) 
Separation of the metabolites of orotate was effected by HPLC 
(Spectra Physics Model 3500 B) of neutralised perchloric acid 
extracts of erythrocytes using an anion exchange column 
(Hichrom APS HVP-2511) (Hichrom, ReadingJ England), with a 
linear buffer gradient developed over 10 min~tes from (5 mM 
KH 2Po 4 (BDH, Aristar grade) pH 2.50) to (500 mM KH 2Po 4 plus 
912 mM KCl, pH 3.8) at a flow rate of 1.2 ml/min. The 
absorbance of the effluent was monitored at 260 nm. Thirty 
second fractions of the effluent were collected, mixed with 
scintillation fluid, 
scintillation system. 
and counted in a Beckman LS-233 
3.2.6 Haemoglobin estimation 
Any haemolysis that may have taken place was estimated by 
measuring the haemoglobin content at the beginning and at the 
end of an experiment using Drabkins reagent which consists of 
(1 mM) and 
adjusted to pH 7.2 with KOH. To 5.0 ml reagent 20 ~1 of 
sample was added and allowed to stand for at least 5 min and 
the absorbance at 540 nm then read against "Drabkins" as 
blank. Multiplying the value thus obtained by 35.8 gives 
the concentration of haemoglobin in g/100 ml. In all 
experiments the degree of haemolysis was less than 3%. 
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3.2.7 Purity of orotate and purification 
Specimens of 14c-orotate (Amersham, U.K.) were subjected to 
anion exchange and reverse phase HPLC before use. If 
necessary, the 14c-orotate was purified by HPLC, using the 
anion exchange column specified above. The orotate fraction 
was eluted using a linear gradient of NH 4COOH from 1 mM to 
1.5 M over 15 minutes. After lyophilisation the orotate-
containing fraction was reconstituted with H2o, and stored at 
-20°C. 
3.2.8 Cell-culture experiments 
Normal fibroblasts were seeded in 6-well Nunc tissue plates 
and grown to confluence in Dulbecco's minimal essential 
medium (DMEM) (Gibco Ltd., Paisley, Scotland) plus 10% foetal 
calf serum (FCS) (Flow Laboratories, Rickmansworth, England) 
at 37°C ~nd 8% co2 in air. Four wells were then washed with 
2 ml medium containing DMEM, 10% FCS, NaH 2Po 4 (10 ~M), HEPES 
(20 mM) and adjusted to pH 7.0 with NaOH. Four more wells 
were washed with the same medium except with pH adjusted to 
7.4; and a further four wells at pH 7.8. 
1 ml Aliquots of medium consisting of (DMEM, FCS (10%), 
NaH2 Po4 (10 mM), HEPES (20 mM), Neomycin sulphate (60 mg/L), 
Streptomycin sulphate (100 mg/L), Sodium benzyl penicillin 
(100 ~g/L), and 14c-orotate (0.2 ~Ci/ml, 61 mCi/mmol) 
(Amersham International, Amersham, England)) was added to 
103 
each of the 12 wells; 4 at pH 7.0, 4 at pH 7.4 and 4 at pH 
7.8. 
400 ~1 Packed washed erythrocytes were then added to 2 of 
each of the sets of 4 wells at each pH and incubated for 4 
hours at 37°C in air. 
The erythrocytes were then quantitatively removed by washing 
with saline and separated from the saline by centrifugation 
through dibutylphthalate. The erythrocytes were then 
precipitated with an equal volume (400 ~1) of 15% TCA. The 
precipitated material was then dissolved in 0.1 M NaOH, 
scintillation fluid added, and counted in a Beckman LS-233 
liquid scintillation counter. 
The fibroblasts (remaining in the wells) were then washed 
three times with 5% TCA to precipitate the protein. The 
precipitate was then dissolved in 1 ml NaOH (0.1 M), 
neutralised with 0.5 ml 6.6% acetic acid, dissolved in 
scintillation fluid and counted. 
3.3 RESULTS 
3.3.1 Transport 
In order 
transport 
to determine the basic kinetics of orotate 
across the erythrocyte membrane, washed 
erythrocytes were incubated for various times at different 
concentrations of 14c-labelled orotate. To prevent-
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metabolism of the transported orotate, phosphate and glucose 
were omitted from the incubation medium, thus avoiding 
accumulation of the PRPP required for metabolism of orotate 
to OMP. HPLC analysis of the labelled erythrocytes confirmed 
(data not shown) that und~r these conditions no conversion of 
orotate to products occurred. The results (Fig. 3.1a) show 
that uptake is linear up to at least 5 min and the secondary 
plot (Fig. 3.1b) of the slopes representing initial velocity 
of uptake, Vi, against orotate concentraiton, shows that 
uptake is non-saturable up to a concentration of at least 4.6 
mmolar, a value close to the maximum solubility of sodium 
orotate in water. 
A competition experiment was performed to determine if 
orotate is transported by the nucleoside transporter (Jarvis, 
1986). Erythrocytes were labelled with orotate for varying 
times in the presence and absence of 10 mmolar uridine. The 
accumulation of orotate with time (Fig. 3.2) was unaffected 
by the uridine indicating that orotate does not cross the 
erythrocyte membrane via the nucleoside transporter. Since 
orotate is an organic anion, competition and inhibitor 
experiments were ·performed to find out whether orotate is 
transported by the 95 K band 3 protein, the general anion 
transporter of the erythrocyte membrane (see section 1.6). 
Both HEPES and bicarbonate are frequently used anionic 
buffers and both inhibited orotate transport at 
concentrations typically employed (Table 3.1). The effect 
of two specific inhibitors of anion transport in the 
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Fig. 3.1 Kinetics of orotate uptake by erythrocytes. 
700 ~1 packed erythrocytes were added to 3 ml medium at 37°C 
consisting of 50 mM HEPES (adjusted to pH 7.4 with NaOH), 14 c 
orotate at the appropriate concentration and adjusted to 
isotonicity with NaCl. 
a) Plot of orotate accumulation with time at external 
orotate concentrations ¢----0, 0.23; ••----••, 0.46; 
, 0.69; ..... ~___,~,., 0.93; 0---0, 1.85; ·--- , 
2.78; o---o, 3.70; and ••----•• ,4.63 millimolar. 
Each measurement was performed in quintuplicate with the 
points representing the mean of these measurements. 
The lines were fitted by the least squares method giving 
coefficients of variation in excess of 0.99 in all 
cases. 
b) Plot of the slopes from (a) versus the corresponding 
orotate concentration. 
U) 
.. 
u 
.a 
~ 
, 
Cl) 
~ 
u 
ca 
~ 
' • ..ca .. 
0 
~ 
0 
• 
• 
-0 
E 
~ 
800 
600 
400 
200 
0 
0 
106 
Fig. 3.1a 
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Effect of uridine on uptake of orotate by 
1 ml packed erythrocytes were added to 3 ml 
medium containing 1.74 mM 14c orotate, 20 mM HEPES, pH 7.4 
adjusted to isotonicity with NaCl, in the presence or absence 
of uridine. Aliquots were taken and delivered into HgC1 2 
stopping solution at the indicated times. Points represent 
the mean of duplicate values which varied from the mean by 
less than 5% in all cases. ••~--•A , in absence of uridine; 
~, in presence of 10 mM uridine. 
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Table 3.1 
Effect of anions on orotate transport 
250 ~1 packed erythrocyte were added in duplicate to 3 ml 
saline-free medium at 25°C containing 1 millimolar 14c-
orotate, and the appropriate quantity of competing anion at 
pH 7.4, and adjusted to isotonicity with sucrose. Aliquots 
were taken at 1 minute intervals for measurement of orotate 
uptake by the dibutylphthalate method and Vi was obtained 
from the slopes of the resulting plots as in Fig. 3.1. The 
duplicated points all fitted straight line plots with 
correlation coefficients better than 0.97. 
ADDITIONS OROTATE Vi 
(~moles/min/1 
packed cells) 
% OF CONTROL 
-----------------------------------------------~------------
No additions 370 100 
HEPES 5 mmolar 143 39 
.. 20 mmolar 117 32 
" 50 mmolar 93 25 
Bicarbonate 24 mmolar 70 19 
1 1 0 
erythrocyte, DIDS and CHCA are given in Table 3.2 and 
demonstrate that transport of orotate is inhibited by both 
compounds. 
} 
In both competitor and inhibitor experiments, tFansport of 
orotate was so rapid in the presence of low concentrations of 
competing anions that it was necessary to perform the 
experiments at 25°C instead of 37°C in order to obtain 
straight line plots for determination of Vi. Hence in a 
medium containing 20 mmol HEPES but lacking chloride anions, 
transport of orotate at 37°C was too rapid to obtain linear 
plots of orotate uptake with time, although the initial rate 
of uptake at 1 mmolar orotate could be assigned a minimum 
value of 530 ~moles/min/1 packed erythrocytes, a value 15 
times greater than the corresponding rate in the presence of 
140 mmolar chloride. Fig. 3.3 illustrates the results of 
orotate uptake in the absence of chloride at 25°C, where the 
Vi for a given concentration of orotate is still 3.2 times 
greater than that in 140 mmolar chloride at 37°C. 
The effect of pH on the initial velocity of orotate uptake 
was measured across the range of 6.2 to 7.8 (Table 3.3). 
There was a broad pH optimum centered at about pH 6.5 but 
transport was still 80% of maximum at pH 7.4. 
The single, selective, anion transport site on band 3 is 
alternating in nature and proceeds via a ping-pong mechanism 
(Gunn and Frohlich, 1979; Falke and Chan, 1985). Under 
1 1 1 
Table 3.2 
Effect of anion transport inhibitors on orotate transport 
200 ~1 packed erythrocytes were added in duplicate to 3 ml 
medium at 25°C, containing the appropriate concentrations of 
inhibitor and 1 mM 14c-orotate, 20 mM HEPES (pH 7.4), 
adjusted to isotonicity with sucrose. Vi was determined as 
described in Table 3.1. Since DIDS is light-sensitive the 
manipulations were performed in very dim light. 
ADDITIONS 
Exp. I 
No additions 
CHCA, 100 ~molar 
CHCA, 500 ~molar 
Exp. I I 
No additions 
DIDS 1 ~molar 
DIDS 5 ~molar 
OROTATE Vi 
(~moles/min/1 packed cells) 
106 
49 
39 
104 
54 
7 
% OF CONTROL 
-100 
47 
37 
100 
52 
7 
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Fig. 3.3. Effect of chloride-free medium on rate of uptake 
of orotate by erythrocytes. 500 ~1 packed erythrocytes were 
added to 4 ml medium at containing varying 
concentrations of 14c-orotate, 20 mM HEPES, pH 7.5 and 
adjusted to isotonicity with sucrose. Aliquots were taken 
at 1 min time intervals for determination of orotate uptake 
and for production of primary plots as in Fig. 3.1a. These 
were all straight line plots with correlation coefficients 
better than 0.98 and their slopes were used for production of 
the secondary plot of initial velocity versus orotate 
concentraiton shown here. 
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Table 3.3 
Effect of pH on orotate uptake by erythrocytes 
250 ~1 packed erythrocytes were added in dupl~cate to medium 
at 37°C containing 1 mmolar 14c-orotate, 20 mmolar HEPES, 
brought to the specified pH with NaOH and adjusted to 
isotonicity with NaCl. Vi values were obtained from the 
linear time course plot as described above. 
------------------------------------------------------------
pH OROTATE Vi 
(~moles/min/1 packed cells) 
------------------------------------------------------------
6.26 
6.66 
7.04 
7.40 
7.76 
38 
40 
36 
32 
31 
------------------------------------------------------------
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conditions where th~re is a relative paucity of anions in the 
incubation medium, there will be a positive inside membrane 
potential (Nicholls, 1982). The band 3 transport mechanism 
should therefore result in the intracellular accumulation of 
a compatible anion to occur at concentrations above those in 
the medium. Erythrocyte Cl- concentration is 50 mH 
(Caraway, 1962) and Fig. 3.4 demonstrates a concentrative 
uptake for orotate in the absence of chloride in the medium. 
After 10 minutes, values for intracellular orotate. 
concentrations reached levels six times greater than the 
initial external orotate concentration. The orotate 
concentration in the erythrocyte took about 3 hrs to reach 
equilibrium values, presumably reflecting the gradual 
dissipation of the positive inside membrane potential. When 
erythrocytes were pre-incubated in chloride-free medium 
containing 1 mH orotate for 16 hours (Fig. 3.5) this allowed 
internal and external orotate concentrations to equilibrate, 
and on addition of a trace quantity of 14c-orotate, 
equilibration occurred rapidly with a half-time of about 7 
minutes. No concentrative uptake was observed. 
3.3.2 Metabolism 
Since metabolism of the orotate transported into the 
erythrocyte is dependent on PRPP, the following experiments 
were performed in glucose and phosphate containing media. 
The dependence of orotate uptake and metabolism in pH and 
inorganic phosphate (Pi) concentration was studied using HPLC 
analysis of PCA extracts of cells incubated in medium 
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Fig. 3.4. Intracellular accumulation of orotate in chloride-
free medium. 500 ~1 packed erythrocytes were added to 5 ml 
of medium at 37°C containing 1 mM 14c-orotate, 10 mM· HEPES, 
pH 7.4, and adjusted to isotonicity with sucrose. 200 ~1 
aliquots were removed at the specified intervals for 
determination of packed erythrocyte orotate concentrations. 
To express the results in mmol/1 erythrocyte water, a 14c-
sucrose dilution was used to determine that under the 
experimental conditions used, packed erythrocytes consisted 
of 70% erythrocytes and 30% extracellular fluid, furthermore, 
under isotonic conditions erythrocytes contain 65-70% water 
by volume (Brewer, 1978). 
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Fig. 3.5. Intracellular accumulation of orotate after 16 
hours pre-incubation in chloride-free medium containing 1 mM 
orotate, 20 mM HEPES, pH 7.4, and adjusted to isotonicity 
with sucrose. A tracer amount (5 x 10-2 ~Ci/ml, equivalent 
to 4 ~molar) of 14c-orotate was added and duplicate samples 
taken for determination of radioactivity at the specified 
time intervals. 
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containing labelled orotate at a concentration of 10 ~molar. 
Fig. 3.6 compares the accumulation of orotate in various 
product species as a function of pH and at varying Pi 
concentrations. Accumulation of label in nucleotides is poor 
in the absence of external phosphate, with UDP sugars being 
the predominant nucleotide species accumulating. However, 
significant quantities of uridine are formed under these 
conditions, and these quantities are not greatly affected by 
pH. Low 
nucleotides. 
pH favours the accumulation of label in 
Increasing phosphate concentrations increase 
the accumulation of label in UTP at all pH values. 
is somewhat different with a Accumulation in 
lesser quantity 
UDP sugars 
of label accumulating at high phosphate 
At alkaline pH concentrations than at intermediate levels. 
(7.8) uridine production increases with increasing phosphate 
concentration, whereas at acid pH values this relationship 
breaks down, with the smallest quantities of uridine being 
formed at the highest external Pi concentrations. The total 
orotate uptake is therefore a complex function of pH and Pi 
concentrations. 
Since the activity of both pyrimidine 5'-nucleotidase and 
PRPP synthetase are regulated by phosphate, the former being 
inhibited (Torrence and Whittaker, 1981) and the latter 
activated (Fox and Kelley, 1971a and b), levels of 
intracellular inorganic phosphate were also measured in the 
above experiment at the varying conditions of pH and external 
Pi. The results in Fig. 3.6 show that intracellular 
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Fig. 3.6. Effect of pH and Pi on orotate metabolism in 
erythrocytes. 200 ~1 fresh, washed, packed erythrocytes were 
incubated for 4 hours at 37°C in 850 ~1 medium containing 10 
mM glucose, 10 ~m 14c-orotate, 20 mm HEPES, NaH 2Po 4 at the 
specified concentrations. pH was adjusted with NaOH, and 
the solution was then adjusted to isotonicity with NaCl. At 
the end of the incubation period, cells were separated from 
medium by the dibutylphthalate method, and phosphate and the 
metabolites of orotate were quantitated in neutralised PCA 
extracts. 
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phosphate concentrations increase proportionately with 
decreasing pH. 
Orotate is known to enter most nucleated cell species only 
relatively slowly (Berman and Harley, 1984). To confirm 
Berman and Harley's findings that erythrocytic conversion of 
orotate to uridine made it available to nucleated cells, 
cultured human skin fibroblasts were labelled with 14 c-
orotate in the presence and absence of erythrocytes at 
varying pH. The results are given in Table 3.4 and show that 
the presence of erythrocytes increased the labelling of 
fibroblast nucleic acids by greater than 10 fold at all pH 
values. 
3.4 DISCUSSION 
Here it is shown that orotate enters erythrocytes with non-
saturable kinetics and with a capacity of 190 ~moles/1 packed 
-
cells/min at a concentration of 4.6 mmolar. This indicates 
that orotate crosses the erythrocyte membrane by either 
simple or unsaturated facilitated diffusion. Saturation 
kinetics could not be determined because of the low 
solubility of orotate (10.8 mM per litre water at 25 °C). The 
presence of competition for transport by a number of anions 
and the lack of competition by uridine is indicative of 
transport by a general anion transporter (facilitated 
diffusion), with the ability for concentrative uptake in 
the absence of other external anions being compatible with 
transport via a ping-pong mechanism (Falke and Chan, 1985). 
Inhibition of transport by the specific band 3 inhibitors 
DIDS and CHCA confirm that transport is via the band 3 
anion transporter. This explains the lack of significant 
uptake of orotate by most differentiated tissues 
(Plagemann, 1971; Imura et al., 1972; Berman and Harley, 
1 2 1 
Table 3.4 
Effect of erythrocytes on incorporation of labelled orotate 
into fibroblasts 
Cultured human skin fibroblasts were labelled with 14c-
orotate in the presence (test) and absence (control) of 
erythrocytes and at varying pH. 
details. 
See Methods (3.2.8) for 
pH Fibroblast acid precipitable material 
(cpm) 
7.0 
7.4 
7.8 
Control 
91 
72 
50 
Test 
890 
769 
603 
1 2 2 
1984) which lack the intact band 3 protein (Kay et ~·, -1983; 
Drenckhahn and Zinke, 1984). However, the demonstration of 
band 3 in rat hepatocytes (Cheng and Levy, 1980) provides a 
mechanism for the orotate transport which has been obs~rved 
in liver (Handschumacher and Coleridge, 1979). 
Fig. 3.7 is a simplified diagram of the metabolism of orotate 
in the human erythrocyte and provides a focus for the 
following discussion. Changes in pH and inorganic phosphate 
concentrations have marked effects on the relative quantities 
of metabolic products produced by the erythrocyte from 
orotate. Since both decreasing pH, and increasing external 
phosphate concentration result in increased intracellular 
phosphate concentrations, an effect seen in Fig. 3.7 and also 
reported previously (Berman et ~., 1988), the increase in 
orotate metabolised with increasing phosphate concentration, 
an effect augmented by lowering the pH, is most easily 
explained by the allosteric activation of PRPP synthetase by 
phosphate (Fox and Kelley, 1971a and b). The increase in 
levels of UTP with decreasing pH may be the consequence both 
of increased PRPP availability for the formation of uridine 
nucleotide from orotate, and decreased conversion of UMP to 
uridine by pyrimidine 5'-nucleotidase, which is known to be 
inhibited by phosphate (Torrence and Whittaker, 1981; Angle 
The accumulation of UDP sugars is optimal at 
a phosphate concentration of 10 mmolar, which is unexplained 
but would be compatible with an inhibitory effect of 
phosphate on CTP synthetase. 
1 2 3 
CTP --- UTP ---- UDPG 
fl 
UDP 
tl 
PP· ~C~:p, 
I OMP . / Uridm~></' 
,..,.. 
,..--- Uridine 
Orotate --
-------4-----------R;;:::::.ane 
Orotate 
Fig. 3.7. Simplified diagram of the metabolism of orotate in 
the human erythrocyte. 
See index for abbreviations. 
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In the studies on the regulation of erythrocyte hypoxanthine 
metabolism by pH and inorganic phosphate described in Chapter 
2, no accumulation of PRPP in erythrocytes was observed when 
incubated at pH values of 7.6 and above in the presence of 10 
mmolar phosphate and no added hypoxanthine, although 
accumulation was readily demonstrable at pH values below 7.4. 
If the lack of PRPP accumulation under these conditions is 
interpreted as a cessation of PRPP synthesis then this result 
is not compatible with the readily demonstrable metabolism of 
orotate, which is a PRPP utilising reaction, in the current 
experiment at alkaline pH values. This apparent paradox can 
be resolved if one assumes that even in the absence of added 
hypoxanthine and demonstrable intracellular IMP there are 
sufficient quantities of hypoxanthine and/or IMP to maintain 
a PRPP wasting cycle at alkaline pH values. The cycle is 
interrupted at acidic pH values as phosphate levels rise and 
inhibit S'-nucleotidase, an effect augmented by the 
decreasing levels of 2,3-bisphosphoglycerate which accompany 
decreasing pH (Bontemps et ~., 1986). 
Earlier studies on orotate uptake in erythrocytes were 
characterised by large variations in the relative quantities 
of. the metabolic products between different experiments 
(Harley et ~., 1986). Now that there is a better 
understanding of the very fine regulation of the erythrocyte 
oxypurine cycle by pH and phosphate (Chapter 2; Berman et 
~., 1988), with PRPP dynamics being markedly altered by pH 
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changes as small as 0.1 units on either side of neutrality, 
it is easier to obtain reproducibility, by maintaining 
erythrocytes in mildly acidic conditions (pH 7.2) and defined 
phosphate concentrations, and using constant pre-incubation 
times, since PRPP accumulates progressively under such 
conditions. 
The kinetics of orotate uptake by erythrocytes and its 
eventual release as uridine provides a role for the 
erythrocyte in the transport and distribution of pyrimidines 
to peripheral tissues, and this model is shown in Fig. 3.8. 
The model shows the capability of the liver to export orotate 
produced by the de novo pathway. This step has been 
demonstrated experimentally using differentiated hepatoma 
cells (Harley et al., 1986) and can be inferred in vivo by 
the demonstrable orotic acid anion of hyperammonaemia. It 
i• a consequence of the stimulation by ammonia of de novo 
synthesis by mitochondrial carbamoyl phosphate synthetase I, 
which is predominantly a liver-specific enzyme. In the next 
step, the erythrocytes take up the orotate secreted by the 
liver into the circulation, convert it to an intermediate 
buffer store of uridine nucleotides, whose distribution is a 
function of pH and phosphate concentration, and eventually 
release it as uridine, which is a readily available form of 
pyrimidine for utilisation by peripheral nucleated cells. 
The enhancement of uptake of labelled orotate into nucleic 
acids of cultured cells by erythrocytes has been demonstrated 
experimentally by Harley et al. (1986), and confirmed here. 
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CTP- nucleic acids 
t/ 
UTP-UDPG 
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Fig. 3.8. Model of whole body pyrimidine circulation. 
Asp, aspartate; OA, orotate; RBC's, erythrocytes. 
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The degradative half of the cycle depicted in Fig. 3.8 
proposes that uracil is the predominant degradative form of 
pyrimidines produced by peripheral cells, and their ulti~ate 
metabolic fate is complete catabolism in the liver to co 2 and 
water (Pihl and Fritzson, 1955). Whereas this is an 
attractive pathway logically, since there is little, if any, 
re-utilisation of uracil by mammalian cells, it is possible 
that a major degradative metabolite is uridine (and cytidine) 
since the predominant fate of uridine when taken up by the 
liver is also degradation via uracil (Harley and Losman, 
198~). 
The metabolic abnormalities in a number of disorders of 
pyrimidine metabolism are consistent with this model. The 
orotic aciduria of hyperammonaemic states has been referred 
to above, and that due to hereditary HPRT deficiency would 
reflect the erythrocyte enzyme defect as well as the liver 
defect; in the former condition the excessive output of 
orotate by the liver exceeds the capacity of the erythrocytes 
to metabolise the orotate, which is a function of its rate of 
PRPP synthesis. In hereditary erythrocyte pyrimidine 5'-
nucleotidase deficiency (Harley et al., 1978; Valentine et 
al•, 1974) the accumulation of erythrocyte nucleotides is a 
logical consequence of orotate uptake, since the Km(apparent) 
for conversion of orotate to nucleotides in the erythrocyte 
is an order of magnitude lower than that for the conversion 
of uridine to nucleotides (Harley and Berman, 1984), which 
also explains why orotate is not normally detectable in the 
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plasma. The thymine-uraciluria found in patients with 
dihydropyrimidine dehydrogenase deficiency (Berger et ~., 
19a4) does not resolve the question as to the predominant 
site of formation of uracil from uridine, but the report of 
massive excretion of uracil and thymine (but not uridine)- in 
the urine of a child with medulloblastoma (Berglund et ~., 
1979) is consistent with the model as illustrated. 
Understanding of the role played by the erythrocyte in the 
transport and metabolism of pyrimidines should also aid in 
the design and application of pyrimidine analogues in the 
treatment of malignant conditions and draw more attention to 
their potential use in the treatment of disorders and 
infections of the erythrocytes themselves. 
\ 
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CHAPTER 4 
REPERFUSION INJURY IN RAT KIDNEYS 
4.1 INTRODUCTION 
There is an increasing body of evidence that reactive oxygen 
species are responsible fot the tissue injury produced by 
reperfusion of ischaemic tissues with oxygenated blood. 
This has been referred to as reperfusion injury (Hearse, 
1977; McCord, 1985; Braunwald and Kloner, 1985; Shlafer et 
al., 1982a and b; Granger et ~· 1981; Flick et al., 1981; 
Manson et ~., 1983; Parks et ~., 1982; Grogard et ~., 
1982; Bulkley, 1983; Del Maestro and Arfors, 1986; Simpson 
and Lucchesi, 1987). 
During ischaemia 
as hypoxanthine 
Newsholme, 1978; 
ATP is rapidly catabolised and accumulates 
and inorganic phosphate (Pi) (Arch and 
Saugstad, 1975; Miller et al., 1978; 
Harkness et ~., 1980; Zimmer, 1984; Harkness et al., 1984; 
Giacomello and Salerno, 1984; Salerno and Giacomello, 1985). 
(In tissues that possess xanthine dehydrogenase, catabolism 
is able to proceed further to xanthine and uric acid, and in 
those animals that have uricase (not man), to allantoin). On 
account of rapid equilibration across the cell membrane 
(Lassen, 1967), the accumulation of hypoxanthine will be both 
intra- and extracellular. In ischaemic renal tissue 
hypoxanthine accumulatioi achieves levels of up to 300 times 
greater than normal (Osswald et ~., 1977). At the same 
time the ATP deficit caused by anoxia results in the 
dissipation of trans-membrane electrochemical gradients which 
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in turn results in the flow of ca 2 + down its concentration 
gradient from 
increase in 
the extracellular 
intracellular ca2+ 
fluid into the cell. This 
activates a proteolytic 
conversion of xanthine dehydrogenase (Type D) to xanthine 
oxidase (Type 0) (Stirpe and Della Corte, 1969; Batelli et 
~., 1972; Waud and Rajagopalan, 1976), a form of the enzyme 
which transfers electrons from hypoxanthine and xanthine to 
oxygen instead of its normal substrate NAD+, with the 
formation of superoxide (Roy and McCord, 1983; Slater, 1985; 
Chambers et al., 1985), (see Fig. 4.4). 
The dramatic conversion of xanthine dehydrogenase to xanthine 
oxidase, demonstrated by Roy and McCord (1983) in support of 
this model for the generation of superoxide, occurred in rat 
intestinal segments that had been subjected to global 
ischaemia with almost total conversion of dehydrogenase (XD) 
to oxidase 
Engerson et 
that, in 
converted to 
(XO) occurring within 1 minute. However, 
al. (1987) in their studies on rats demonstrated 
response to global ischaemia, tissue XD was 
XO in all tissues with half-times of conversion 
at 37°C of 3.6, 6, 7 and 14 hours for the liver, kidney, 
heart and lung respectively. It is a matter of conjecture 
as to whether these significantly longer half times are in a 
time frame consistent with the ischaemia-reperfusion injury 
process. Furthermore, the activity of XO in brain (and some 
other tissues) is substantially lower than in other tissues 
(Del Maestro and Arfors, 1986, pp. 92 and 93), a tissue that 
is easily damaged by hypoxia (Siesjo, 1987). The 
inhomogeneity of distribution of the XD-XO enzyme system in 
endothelial cells and in a number of organs suggests that a 
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degree of variability may exist in the importance of this 
enzymatic free radical generation in the reperfusion of 
different organs after ischaemia. The absence of results, 
suggesting a role for scavenging enzymes (e.g. SOD) in 
cerebral ischaemia and reperfusion may reflect the low levels 
of these enzymes present in brain capillaries (Del Maestro 
and Arfors, 1986, epilogue). 
Therapeutic approaches to tackle the problem of reperfusion 
injury have included the prevention of superoxide generation 
' from hypoxanthine by the use of inhibitors such as 
allopurinol (Cunningham et al., 1974). A second approach"is 
the removal of superoxide, as it is formed, by the use of 
free radical scavengers, such as superoxide dismutase (Del 
Maestro, 1980; Granger et ~., 1981; Lefer et al., 1981; 
Shlafer et al., 1982a and b; Jolly et al., 1984). 
A third approach would be to remove hypoxanthine from anoxic 
tissues prior to re-exposure to oxygen. In Chapter 2 the 
ability of human erythrocytes to metabolise hypoxanthine to 
IMP was demonstrated to be dependent on unphysiologically 
high phosphate concentrations. This has also been shown by 
Giacomello and Salerno (1979 and 1984); Hershko et al. (1967 
and 1969); and Gutenson (1975). High phosphate 
concentrations have been demonstrated in ischaemic tissues 
(Garlick et ~., 1979; Radda, 1983; Radda et ~., 1983; 
and Arnold et al., 1984). The concentration of ATP in whole 
muscle has been measured at S.S mmol/kg (Harris et ~., 
1974). On complete degradation this could potentially 
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generate a local concentration of about 15 mM inorganic 
phosphate in the ischaemic tissue. Creatine phosphate would 
further contribute to the increase in phosphate concentration 
in cardiac and skeletal muscle; potentially another 35 mM. 
The inorganic phosphate concentrations generated in ischaemic 
tissue should therefore be sufficient to stimulate 
significant hypoxanthine uptake by erythrocytes either 
resident in capillaries in the anoxic tissue, or introduced 
on reperfusion of the anoxic tissue. 
In this chapter, the development of a model of renal 
ischaemia in the rat is described. The ability of human 
erythrocytes, "primed" by preincubating in acid medium of 
high phosphate concentratiort and low oxygen tension, to take 
up hypoxanthine in a concentrative manner when perfused 
through ischaemic rat kidney is demonstrated. Attempts to 
demonstrate improved survival and renal function in rats 
whose ischaemic kidneys had been perfused with "primed" human 
erythrocytes 
unsuccessful. 
prior 
It is further 
to reperfusion were, however, 
demonstrated that "unprimed" human 
erythrocytes, resident in ischaemic rat kidney for 3 hours, 
take up hypoxanthine and convert it to IMP. This suggests 
that erythrocytes could play a physiological role in the 
prevention of reperfusion injury. 
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4.2 MATERIALS AND METHODS 
4.2.1 Washing of erythrocytes 
Venous blood was sampled from healthy human volunteers into 
commercial, lithium heparin-containing vacuum tubes and 
centrifuged and washed as described in section (2.2.1). 
4.2.2 Preparation of "unprimed" erythrocytes 
Freshly washed human erythrocytes were resuspended to a 
haemotocrit of 0.33 in medium containing glucose (10 mM), 
HEPES (20 mM, and adjusted to pH 7.4 with NaOH) and NaCl to 
' adjust to isotonicity. This suspension was designated 
"unprimed" erythrocytes. 
4.2.3 Preparation of "primed" erythrocytes 
Freshly washed human erythrocytes were suspended in medium, 
(packed cell volume to medium ratio approximately 1:4), 
containing glucose (10 mM), NaH2 Po4 (20 mM, pH adjusted to 
7.2 with NaOH), HEPES (20 mM, pH adjusted to 7.,2 with NaOH) 
and NaCl to adjust to isotonicity and incubated for 3 hours 
at 37°C with continuous gentle shaking. The suspension was 
then centrifuged for 5 minutes at 1700 x g and the packed 
erythrocytes resuspended in fresh medium of the same 
composition to a haematocrit of 0.33 and kept at 0-4°C till 
used later the same day. 
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4.2.4 Sampling of blood from rats 
The rats were first anaesthetised in a glass bell jar 
containing ether and then blood was obtained from the retro-
orbital plexus of veins by inserting the tip of a Pasteur 
pipette between the medial epicanthus and the medial border 
of the globe and 
into the pipette. 
allowing the blood to spontaneously flow 
No more than 1 ml of blood was sampled 
from any rat on a given day. The animals appeared to 
tolerate this procedure without any untoward effects; 
specifically, there was no adverse injury of local anatomy 
and there did not appear to be any visual impairment. 
Immediately after sampling, the blood was inserted into glass 
tubes, allowed to clot and then centrifuged at approximately 
3000 x g for 5 minutes. The separated serum was used for 
creatinine estimation. 
4.2.5 Preparation of erythrocytes for HPLC 
Erythrocyte suspensions were prepared for HPLC as described 
in section 3.2.1. 
4.2.6 HPLC 
High pressure liquid chromatography (HPLC) was carried out as 
described in section 2.2.5. 
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4.2.7 Creatinine determination 
0.5 ml of serum was mixed with 0.5 ml H2o, 0.5 ml 5% Sodium 
Tungstate and 0.5 ml 0.33 M H2 so4 , and allowed to stand for 
ten minutes. The precipitate was then deposited by 
centrifugation and then 250 ~1 saturated Picric Acid and 250 
~1 0.75 M NaOH added to 750 ~1 of the supernatant and the 
J 
mixture allowed to stand for 20-45 minutes before reading the 
absorbance at 520 nm. A 100 ~M creatinine standard was used 
and H2o used as a blank. 
4.2.8 The model and surgical procedure 
' 
Adult male Long Evans (L.E.) rats weighing between 250 and 
350 g were anaesthetised by placing them in a glass bell-jar 
containing ether-soaked cotton wool and then given 
intramuscular Ketamine Hydrochloride (Ketalar) in a dose of 1 
mg per 100 g body weight. The animals were then taped by 
their ankles, ventral surface up, to a cork-surfaced 
operating board and anaesthesia maintained using ether in a 
cottonwool-containing nose cone, and intermittent "topping 
up" doses of 0.1 - 0.2 mg Ketalar per 100 g body weight. 
Survival is improved if minimal ether anaesthetia is used and 
smaller, more frequent doses of Ketalar administered as 
required rather than a single maximum bolus dose. 
After shaving the fur from the abdominal wall and cleansing 
the skin with Hibitane in alcohol the abdomen was entered via 
a longitudinal incision from the xiphisternum and extending 
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sufficiently inferior to allow adequate access for the 
isolation of the kidneys. Appropriately bent paper clips 
attached to rubber bands anchored to the operating board 
served as retractors bilaterally. 
After reflecting the liver superiorly out of the abdominal 
cavity and maintaining it there with a saline soaked gauze 
swab the intestines were reflected extracorporeally to the 
animal's left to allow access to the right kidney which was 
then removed after dissecting it free from the posterior 
abdominal wall and placing a silk ligature around the renal 
vessels and ureter. 
To gain access to the lef~ kidney, the intestines were 
reflected extracorporeally to the animal's right and covered 
with a saline-soaked gauze swab. 
Microsurgical instruments and an operating microscope (Nikon) 
with a capacity for 4-40 times magnification were used for 
the microsurgery described below. 
In this model the left kidney has a fairly long vascular 
pedicle, usually comprising a large renal vein and a smaller 
renal artery, which, proximally, lies posterior to the vein 
but on its course to the renal hilum lies superiorly and then 
antero-superiorly to the vein at the hilum. The adrenal 
artery arises from the superior aspect and approximately 
half-way along the renal artery. In four percent of the 200 
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animals dissected there was some variation in this pattern. 
In some, the renal artery was double, with origins from the 
aorta above and below the renal vein and in a smaller 
proportion there was an anomalous blood supply to the kidney, 
one from a branch of the adrenal artery to the upper pole_of 
the kidney and in another animal there was an early division 
of the renal artery after its takeoff from the aorta. Such 
anomalies made cannulation and control of the blood supply 
difficult and these animals were therefore excluded on 
identification. 
After cauterisation of the adrenal artery, the (left) renal 
artery and vein were dissected free from surrounding tissue 
so as to allow the placement, but not tying, of silk 
ligatures proximally and distally on each vessel. The 
proximal ligature serves to occlude blood flow and the 
function of the distal ligature, when required, is to retain 
and prevent leakage past an intravascular cannula. To 
ensure complete ischaemia, the peritoneum over the periphery 
of the kidney was incised and the kidney then dissected free 
from its retroperitoneal bed, and the ureter with its 
colateral vessels clamped. 
Prior to occluding any vessels, the rat was heparinized by 
injecting 0.1 units of heparin per gram body weight via the 
dorsal vein of the penis using a 26 gauge needle. The 
solution of heparin diluted in saline containied 50 units per 
ml; each rat therefore required approximately 30 units of 
heparin and this was given in a volume of 0.6 ml. 
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Following heparinisation, the ureteric clamp was placed and 
the proximal arterial ligature tightened. Adequate 
ischaemia was evidenced by immediate blanching of the kidney. 
If this was apparent, the time was noted and the vein 
similarly ligated. 
elapsed between 
The ischaemic interval was the time 
renal artery ligation and the kidney 
reperfusion that occurred after this (proximal) renal artery 
ligature was cut free. 
Having ligated the vessels and rendered the kidney ischaemic, 
where indicated, the next step was to cannulate the renal 
vessels. The renal artery between the tight proximal 
ligature and the loose distal one was cleaned of loose 
connective tissue and small branches cauterized. A ligature 
tied around the base of the overlying adrenal vein as it 
enters the renal vein made a useful handhold for retracting 
the renal vein, thus improving access to the renal artery. 
After exposure and cleaning of the renal artery a small 
arteriotomy was performed using microscissors and the vessel 
cannulated with a 24 gauge "Bardi-cath" catheter (C.R. Bard 
International Ltd., Sunderland, England; P. No. 2012), 
previously primed with the appropriate solution, and secured 
by tying the distal ligature. The catheter was used over 
and again by keeping it clean, using Hibitane and water, but 
not sterile. It could be kept soft and pliable by 
occasionally rubbing it with glycerine. -The vein was 
cannulated in a similar manner using a 22 gauge "Jelco" 
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intravenous catheter (Criticon, Tampa, 
4053). The perfusion conditions are 
USA; order number 
defined for each 
experiment. 
otherwise. 
The flow rate was 0.5 ml/min unless specified 
4.2.9 Perfusion apparatus 
~ peristaltic, non-occlusive, pump (LKB, Bromma, USA) was 
attached to the arterial cannula using fine bore siliconized 
tubing to carry the specified perfusate from a reservoir 
immersed in a 37°C water bath to the 24 gauge arterial 
cannula. When required, the perfusate eluting from the 
kidney via the 22 gauge renal vein cannula was collected. 
Appropriately cut Biofusion anaesthetic extension sets 
(Biofusion (Pty) Ltd, Johannesburg, South Africa; E x 90) 
proved useful in making some of the necessary connections. 
When indicated, a three-way stop-cock interposed between the 
lines from two "feeding" solutions (saline and blood) in the 
37°C water-bath and the peristaltic pump simplified the 
changing from one perfusing solution to the other. 
On completion of the perfusion the cannulae were removed in 
reverse order and the vessels repaired. The vein was 
repaired using a continuous 8-0 nylon suture and the artery 
with interrupted 10-0 nylon sutures. After the repairs, 
first the venous and then the arterial ligatures were removed 
to re-establish normal 
returned to its normal 
repair was aqequate. 
renal blood-flow. The 
colour within three minutes 
kidney 
if the 
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4.2.10 Deoxygenation of solutions 
Solutions that were used to perfuse kidneys after a period of 
ischaemia were deoxygenated to a p0 2 < 3.0 kPa by slowly 
bubbling helium gas through the solutions (in their capped 
reservoirs suspended in the 37°C water-bath) for at least 
half an hour prior to use. 
4.3 RESULTS 
4.3.1 The ability of "primed" erythrocytes to form IMP from 
hypoxanthine in ischaemic rat kidney 
To investigate the ability of primed erythrocytes to take up 
hypoxanthine (Hx) from ischaemic rat kidney and convert it to 
inosine 5'-monophosphate (IMP), ischaemic rat kidneys were 
separately perfused with either "primed" or "unprimed" 
erythrocytes. The effluent erythrocytes were analysed for 
their hypoxanthine and IMP content using reverse phase and 
anion exchange HPLC. The results are shown in Figure 4.1 
and demonstrate that "primed" erythrocytes are more efficient 
at clearing the ischaemic kidney of hypoxanthine than 
"unprimed" erythrocytes. This can be deduced from the fact 
that tissue and erythrocyte hypoxanthine levels equilibrate 
within a matter of seconds at 37°C (Muller and Falkner, 
1976); the erythrocyte hypoxanthine levels thus closely 
reflect the tissue hypoxanthine levels. The results 
demonstrate that the primed erythrocytes are able to do this 
by converting hypoxanthine to IMP, thus taking hypoxanthine 
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Figure 4.1. The ability of "primed" erythrocytes to form 
IMP from hypoxanthine in ischaemic rat kidney. Isolated rat 
kidneys were subjected to warm renal ischaemia for 1 hour and 
then separately perfused with either "primed" or "unprimed" 
human erythrocytes. The effluent erythrocytes were analysed 
for their hypoxanthine and IMP contents using reverse phase 
and anion exchange HPLC. Hx, hypoxanthine; IMP, inosine 
5'-monophosphate; RBC, erythrocytes; Total, total oxypurine 
content (i.e., Hx + IMP). e e, "primed" erythrocytes; 
• • , "unprimed" erythrocytes. 
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up in a concentrative manner. In contrast, no IMP was 
detected in the unprimed erythrocytes. It can be seen that 
because of this concentrative uptake of hypoxanthine, the 
total oxypurine (hypoxanthine + IMP) content of the "primed" 
erythrocytes at two minutes is double that of the "unprimed" 
erythrocytes. This difference decreases with the passage of 
time as the hypoxanthine level in the kidney perfused with 
"primed" cells decreases more rapidly, and at 10 minutes 
hypoxanthine levels are less than one-third those found in 
the kidney perfused with "unprimed" cells. Figure 4.2 shows 
the anion exchange HPLC profiles of erythrocytes eluting 
during the third minute of perfusion. The presence of the 
IMP peak in the "primed" erythrocytes, and its absence in the 
"unprimed" eryth~ocytes is demonstrated. The identity·of 
the IMP peak was confirmed by spiking. The identity of the 
hypoxanthine peak was confirmed by spiking and by the fact 
that the peak was eliminated by the addition of xanthine 
oxidase (Boehringer) to a sample prior to HPLC analysis. 
4.3.1 Ability of "primed" human erythrocytes to remove 
hypoxanthine from ischaemic rat kidney 
To demonstrate that "primed" erythrocytes are more efficient 
than "unprimed" erythrocytes at removing hypoxanthine from 
ischaemic tissue, the renal artery and vein of kidneys that 
had been removed from adult male Long Evans rats were 
cannulated and incubated in a humidified environment at 37°C 
for 1 hour. The kidneys were then perfused at a rate of ~ 
ml per minute with either "primed" or "unprimed" erythrocytes 
r 
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Figure 4.2. HPLC profiles of acid soluble material in 
"unprimed", A, and "primed", B, human erythrocytes after 
perfusion through ischaemic rat kidney. Neutralised PCA 
extracts of "primed" and "unprimed" human erythrocytes 
eluting from ischaemic rat kidney during the third minute of 
perfusion in the experiment described in Figure 4.1 were 
subjected to anion exchange HPLC to quantitate their inosine 
5'-monophosphate (IMP) content. Chromatographic conditions 
are described in section 2.2.5. 
Hx, hypoxanthine. 
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for 10 minutes. The kidneys were then snap frozen in liquid 
nitrogen, freeze dried and then analysed for their 
hypoxanthine content using HPLC. The contralateral kidney, 
which was also incubated for 70 minutes at 37°C but not 
perfused, was used as a control in each perfusion experiment. 
The results, which are given in Table 4.1, show that "primed" 
erythrocytes are more efficient at removing hypoxanthine from 
ischaemic rat kidney than "unprimed" erythrocytes. 
4.3.3 The ability of "unprimed" human erythrocytes resident 
in ischaemic rat kidney to take up and convert 
hypoxanthine to IMP 
PRPP formation in erythrocytes is partly dependent upon the 
p~esence of unphysiologically high levels of inorganic 
phosphate (Pi) (Hershko et al., 1969; Giacomello and 
Salerno, 1979). It is known that Pi levels in ischaemic 
tissue rise significantly, possibly as high as 20-25 
millimolar (Garlick et ~., 1979; Osswald et al., 19~7; 
Radda, 1983; Radda et ~., 1983; Sorlie et ~., 1982). To 
determine whether "unprimed" human erythrocytes resident in 
ischaemic tissue are exposed to sufficiently high levels of 
Pi to stimulate the formation of PRPP and thus the uptake and 
conversion of hypoxanthine to IMP, human erythrocytes 
suspended in HEPES (20 mM; pH 7.4), glucose (10 mM) and 
adjusted to isotonicity with NaCl (but no Pi) were incubated 
in duplicate in ischaemic rat kidney for 3 hours at 37°C. 
The erythrocytes were then flushed out, separated from the 
medium by centrifuging through dibutylphthalate and then 
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TABLE 4.1 
Hypoxanthine content of ischaemic rat kidney after the 
passage of either "primed" or "unpiimed" human erythrocytes. 
"Unprimed" 
erythrocytes 
1 
2 
3 
~g Hx/g kidney (dry wt) 
Control 
1269 
580 
429 
Test 
1050 
340 
103 
Difference 
219 
240 
326 
------------------------------------------------------------
"Primed" 
erythrocytes 
4 
5 
6 
810 
1152 
1303 
271 
325 
475 
539 
877 
828 
------------------------------------------------------------
Hx, hypoxanthine. 
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analysed for their IMP and hypoxanthine contents using HPLC. 
Control erythrocytes, suspended in the same medium but not 
perfused into a kidney, were incubated in vitro for the same 
time period, also at 
4.2 and show that 
37°C. The results are given in Table 
IMP accumulated in the "resident" 
erythrocytes to a mean level of 68 micromoles per litre of 
Predictably, no hypoxanthine was packed erythrocytes. 
detectable in the control erythrocytes. The mean 
hypoxanthine level in the 
micromoles per litre of 
agreement with the levels 
Osswald et al. (1977). 
"resident" erythrocytes was 315 
packed erythrocytes, a figure in 
found in ischaemic rat kidneys by 
ATP levels in both control and test 
erythrocytes were in the physiological range. 
4.3.4 Effect of storage on the ability of "primed" 
erythrocytes to convert hypoxanthine to IMP 
To determine the effect of storage on the ability of "primed" 
erythrocytes to convert hypoxanthine to IMP a batch of 
"primed" erythrocytes was prepared as described in section 
4.2.3, stored and their ability to convert 
hypoxanthine to IMP analysed at weekly intervals by 
incubating at 37°C for 10 minutes in medium containing HEPES 
(20 mM, pH adjusted to pH 7.2 with NaOH); hypoxanthine, 1 
mM; and adjusted to isotonicity with NaCl. The erythrocytes 
were suspended in the medium to a haemotocrit of 0.25. The 
cells were separated from the medium and prepared for HPLC as 
described in section 2.2.1. Anion exchange HPLC was carried 
out as described in section 2.2.5. The results are given in 
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TABLE 4.2 
Purine content of human erythrocytes resident in ischaemic 
rat kidney 
Control 
Test 1 
Test 2 
Mean of 1 & 2 
Hx 
micromoles/1 
packed rbc's 
nil detected 
310 
320 
315 
IMP 
micromoles/1 
packed rbc's 
nil detected 
64 
71 
68 
ATP 
mmoles/1 
packed rbc's 
1.0 
1.5 
1.3 
1.4 
Hx, hypoxanthine; IMP, inosine monophosphate. 
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Table 4.3 and show that there is a decrease from 320 
micromoles per litre packed erythrocytes on day 0 to 120 
micromoles per litre packed erythrocytes on day 14. 
4.3.5 Survival statistics in heminephrectomised rats 
subjected to warm renal ischaemia (not cannulated) 
To establish survival statistics four cohorts of ten rats 
were heminephrectomised and the remaining (uncannulated) 
kidney rendered ischaemic for varying lengths of time 
(specified), each cohort being subjected to different periods 
of ischaemia. Blood samples were taken on the days 
indicated for plasma creatinine 
survival of the animals recorded. 
determination and the 
The results are given in 
Table 4.4 and reveal that after 1, 1.5, 2.25 and 3 hours 
ischaemia the mortality rates at day 
90%, respectively. Typically, plasma 
10 were 0, 10, 70 and 
creatinine rose to 
maximum levels on day 2, whereupon the rats either died or 
the plasma creatinine dropped back to normal levels by day 8. 
4.3.6 Development of renal vascular cannulation and 
perfusion technique 
To develop a renal vascular cannulation and perfusion 
technique, 40 Long Evans rats were subjected to left 
nephrectomy and a variety of methods of isolating and 
perfusing the remaining right kidney. The technique which 
produced the most favourable survival statistics was evolved 
and is described in section 4.2.8. 
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TABLE 4.3 
Effect of storage on "primed" erythrocytes 
Human erythrocytes were prepared, stored and analysed in 
duplicate for their ability to convert hypoxanthine to IMP. 
The mean values are shown and were found to vary from their 
duplicates by less than 10%. 
Day 
0 
7 
14 
IMP 
micromoles/1 packed rbc's 
320 
174 
120 
IMP, inosine monophosphate 
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TABLE 4.4 
Survival statistics in heminephrectomised rats subjected to 
warm renal ischaemia (not cannulated) 
Four cohorts of ten heminephrectomised rats were each 
subjected to different periods of renal ischaemia and their 
subsequent survival and plasma creatinine levels followed• 
Renal ischaemic 
time (hours) 
1.0 
1.5 
2.25 
3.0 
Day 
0 
2 
4 
6 
8 
10 
0 
2 
4 
6 
8 
0 
2 
4 
6 
8 
0 
2 
4 
6 
SO, standard deviation. 
Mean plasma creatinine 
in mg/100 ml (1 SO) 
1.16 
1.41 
1.22 
1.28 
1.41 
1.24 
1.36 
2.87 
1.59 
1.16 
1.09 
0.81 
7.50 
4.72 
2.20 
1.24 
1.27 
9.8 
2.17 
1.35 
(0.41) 
(0.39) 
(0.08) 
(0.24) 
(0.23) 
(0.19) 
(0.23) 
( 1. 27) 
(0.28) 
(0.24) 
(0.15) 
(0.28) 
(2.94) 
(3.89) 
( 1. 79) 
(0.14) 
(0.17) 
(3.65) 
(3.65) 
(3.65) 
Survival 
100% 
90% 
70% 
10% 
1 5 1 
Concomitantly, attempts were made to reproduce the results 
shown in Table 4.4, but with the left renal artery cannulated 
and subsequently repaired. 
to more than 90 minutes 
Without exception, rats subjected 
of warm renal ischaemia, with 
associated renal artery c~nnulation and repair, died within 
48 hours. Thus, the protocol of 1 hour total warm renal 
ischaemia, with a 10 minute period of perfusion included, was 
evolved. The perfusion period of 10 minutes was selected 
somewhat arbitrarily as this allowed time for cannulation, 
perfusion and vascular repair, all within the hour's 
ischaamic time. As the operator became more skilled, the 
vascular repair took les~ time and the perfusion period could 
thus be extended. For the purposes of this study, however, 
the perfusion period was kept at 10 minutes. 
It was found that the cannulation and repair of the renal 
vasculature significantly reduced the warm renal ischaemia 
which a heminephrectomised rat can tolerate. From a 
mortality rate of 10% after 1.5 hours warm renal ischaemia 
with no breaching of vessel walls, the mortality rate rose to 
70% for the same period of ischaemia, but with associated 
cannulation and repair. 
4.3.7 Survival in rats subjected to warm renal ischaemia 
and subsequent perfusion with "primed" erythrocytes 
To determine if the perfusion of kidneys of rats subjected to 
warm renal ischaemia with "primed" erythrocytes could improve 
their survival, four cohorts of twenty adult male Long Evans 
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rats were established. One cohort was the experimental 
group and these animals were subjected to perfusion with 
freshly "primed" erythrocytes (haematocrit, 0.33). Three 
control groups formed the other cohorts and comprised the 
following: 
(a) Technique control: animals were subjected to renal 
artery and vein cannulation and repair but were not perfused. 
(b "Unprimed" erythrocyte control: the cannulated kidneys 
were perfused for 10 minutes with fresh, saline washed, 
"unprimed" human erythrocytes suspended in normal saline to a 
haematocrit of 0.33. 
(c) Perfusion control: renal arteries and veins were 
cannulated and repaired but the kidneys were perfused with 
warm saline only. 
Apart from the perfusion differences between the four cohorts 
all animals were treated similarly. The operative and 
perfusion techniques are described in sections 4.2.8 and 
4.2.9, respectively. Plasma creatinine levels were 
determined by the method described in section 4.2.7. The 
survival rates of the four cohorts at day 8 are given in 
Table 4.5. A one-way analysis of variance was used to 
compare the four cohorts, and no significant differences in 
survival could be found. The mean plasma creatinine levels 
are given in Table 4.6 and in graphical form in Figure 4.3. 
In concordance with the survival rates, no significant 
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TABLE 4.5 
Survival rates post warm renal ischaemia and cannulation, 
with and without perfusion. 
Cohort 
No perfusion 
"Unprimed" 
erythrocytes 
"Primed" 
erythrocytes 
Saline 
Number of rats surviving 
Day: 9 1 2 4 
19 18 11 9 
18 10 6 7 
19 8 8 7 
21 15 8 6 
6 8 
8 7 
6 6 
6 6 
6 6 
____________________________________________________________ y 
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TABLE 4.6 
Mean plasma creatinine levels post warm renal ischaemia and 
cannulation, with and without perfusion 
These results are presented in graphical form in Figure 4.3. 
-------------------~----------------------------------------
Cohort 
No Perfusion 
(n = 19) 
Plasma creatinine in mg% (1 Std. Dev.) 
Day: 0 
1.02 
(0.37) 
1 
3.4 
(1.02) 
2 
3.9 
( 1. 9) 
4 
2.14 
( 1 • 2 ) 
6 
2.18 
( 1 • 3 ) 
8 
1.54 
(0.68) 
------------------------------------------------------------. 
"Unprimed" 
erythrocytes 
(n = 18) 
"Primed" 
erythrocytes 
(n = 19) 
Saline 
(n = 21) 
1.16 
(0.73) 
0.88 
(0.33) 
1.15 
(0.46) 
4.46 
(1.0) 
1.95 1.81 1.76 
(0.54) (0.61) (0.9) 
1.3 
(0.47) 
4.2 
(0.66) 
4.32 2.29 
(2.09) (1.5) 
4.78 4.8 3.9 
( 1. 6) (0.92) (1.4) 
1.5 1.18 
(1.12) (0.46) 
2.98 1.8 
(1.67) (0.53) 
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Figure 4.3. Mean plasma creatinine levels post warm renal 
ischaemia and cannulation, with and without perfusion. Four 
cohorts of approximately 20 rats were subjected to warm renal 
ischaemia and cannulation, with and without perfusion as 
described in section 4.3.7. The graphs in this figure are 
plotted from the results presented in Table 4.6 where the 
number of rats in each cohort and the standard deviations of 
the mean values are given. ._ __ .. , no perfusion; o----o , 
perfused with "unprimed" erythrocytes; •· • • • ·• , perfused 
with "primed" erythrocytes; ~ , perfused with saline. 
1 5 6 . 
differences are seen between the creatinine levels in the 
four cohorts. 
4.4 DISCUSSION 
Superoxide radical-induced •cytotoxicity appears to depend 
largely on the subsequent production of a highly reactive 
species, the hydroxyl radical (or its redox equivalent) 
catalyzed by iron, which is probably in the form of an 
organic iron complex (Wilson, 1984; Halliwell and 
Gutteridge, 1984), (see Fig. 4.4). Upon reperfusion of 
previously ischaemic tissue, reactive oxygen species are 
implicated as the cause of increased permeability of cell 
membranes of endothelium and epithelium. Increased 
permeability in cell membranes of tubular epithelial cells or 
capillary endothelial cells could lead to disruption of vital 
transport functions. Membrane damage by reactive oxygen 
species could occur at the plasmalemma with secondary release 
of other mediators such as lipid endoperoxides, ara~hidonic 
acid, and hydroperoxides. Either these mediators or the 
initiating species could induce endothelial cell contraction 
terminating in a macromolecular leak (Del Maestro et ~., 
1980). The hydroxyl free radical has been shown to degrade 
hyaluronic acid (McCord, 1974), which is one of the principal 
constituents of the interstitial matrix and the capillary 
basement membrane (Altura, 1980). Oxygen free radical-
induced damage to the capillary basement membrane could 
exacerbate the microvascular leak already established as a 
result of endothelial cell damage. 
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Figure 4.4. Scheme depicting the proposed mechanism for the 
production of superoxide anion free radical (02 ~) and other 
reactive oxygen species after transient ischaemia followed by 
reperfusion with oxygenated blood. Superoxide dismutase 
(SOD) catalytically removes o2 ; generated from all possible 
sources (modified from McCord, 1985). XD, xanthine 
dehydrogenase; XO, xanthine oxidase; SOD, superoxide 
dismutase; o2;, superoxide; OH•, hydroxyl radical. 
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The findings of Baker et ~· (1985) support the proposal that 
o2 i plays a critical role in the structural and functional 
damage to kidneys that results from reoxygenation of 
ischaemic tissue and further that the oxygen radicals are in 
part derived from the action of xanthine oxidase. 
The studies in this thesis demonstrate that human 
erythrocytes, "primed" by preincubating in medium of low pH 
and high inorganic phosphate concentration to increase their 
(intracellular) PRPP levels, are able to take up hypoxanthine 
from ischaemic rat kidney in a concentrative manner by 
converting it to IMP, whereas "unprimed" erythrocytes are not 
able to do so. It is also demonstrated that these "primed" 
erythrocytes are quantitatively more efficient at removing 
hypoxanthine that has accumulated in ischaemic rat kidney. 
However, after development of a rat model of renal ischaemia 
and a technique of vascular cannulation and renal perfusion~ 
no improved survival or renal function could be demonstrated 
in rats whose ischaemic kidneys were perfused with "primed" 
human erythrocytes over those rats whose ischaemic kidneys 
were perfused with "unprimed" cells. Whilst this result 
does not support the role of oxygen free radical-induced 
damage in kidneys subjected to warm ischaemia .and 
reperfusion, as did the work of Baker et al. (1985), it does 
not disprove it, as, whilst the "primed" cells were more 
efficient at hypoxanthine removal from the ischaemic tissue 
there was still some hypoxanthine remaining in the kidneys at 
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the time of reperfusion, and this could have been sufficient 
to lead to an initiation of the free radical chain reaction 
that could result in the destruction of cells (Esterbauer et 
A!·, 1982). 
Furthermore, a longer ischaemic time (approximately 2~ hours) 
was required to produce 50% survival in the (Long Evans) rats 
used in. the experiments described in 
only 45 minutes ischaemic time 
this thesis, 
was required 
whereas 
in the 
experiments of Baker et al. (1985) where male LBNF 1 rats 
were used. There is no immediately apparent explanation for 
this difference; certainly, the renal ischaemia in the 
experiments described here was complete. Perhaps the 
defence. mechanisms against reperfusion injury (e.g. 
superoxide dismutase activity) of the Long Evans rats used 
here are more effective than those of the rats used by Baker 
et Al· The relevance of the longer ischaemic time used here 
to produce injury, is that whilst superoxide radicals might 
act as primary mediators of ischaemic tissue injury, with 
more severe or prolonged periods of ischaemia, other factors 
such as ATP depletion and proteolysis may play a more 
important role in the chemical and structural alteration of 
tissue (Baker et al., 1985). These other factors could then 
negate the protective effects offered by lowering tissue 
hypoxanthine in ischaemic tissue prior to reperfusion with 
oxygen rich blood. 
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The effect of storage on the capacity of "primed" human 
erythrocytes to convert hypoxanthine to IMP 
determined, indicating that this capacity is 
halved in 7 to 10 days of storage at 4°C. 
has here been 
approximately 
This has time-
saving implications in conducting experiments in the future; 
fresh batches of "primed" erythrocytes need not be prepared 
every day. 
Also demonstrated here, is that unprimed human erythrocytes 
left resident in ischaemic rat kidney for 3 hours, are able 
to take up accumulated hypoxanthine and convert it to IMP. 
One can conclude then, that to account for the conversion of 
hypoxanthine to IMP, PRPP has been generated in these 
erythrocytes, indicating that sufficient inorganic phosphate 
and hydrogen ions have accumulated in the ischaemic tissue to 
promote the formation of PRPP (see Introduction of this 
~hapter). This has possible pathophysiologic implications. 
Perhaps, during a temporary cessation in blood flow to an 
organ (such as may occur in the kidneys and intestines of the 
injured mammal in hypovalaemic shock) the erythrocytes 
trapped in the ischaemic tissue are able to generate 
sufficient PRPP to remove enough accumulating hypoxanthine 
from the tissue to reduce reperfusion injury should blood 
flow be re-established. 
1 6 1 
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